<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC2017-2018_S08_ch09_p205-242</title>
		<link href="BCSC2017-2018_S08_ch09_p205-242-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC2017-2018_S08_ch09_p205-242" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span>9</p>
			<p class="chapter-title">Infectious Diseases of the External Eye: Basic Concepts and Viral Infections</p>
			<p class="h1 ParaOverride-1">Highlights</p>
			 <div id="Chapt9_Top1">
			<ul>
			<p class="body-text--no-indent-">
				<li class="bullet-list-mid">Tetracaine provides better conjunctival anesthesia than proparacaine hydrochloride; however, it has antimicrobial properties that may interfere with organism recovery when cultures are performed.</li>
				<li class="bullet-list-mid">Most organisms are eventually cleared from the site of an acute infection, but some persist in the host indefinitely. For example, after primary infection, herpes simplex virus and varicella-&#173;zoster virus establish latency in trigeminal ganglion cells.</li>
				<li class="bullet-list-mid">Topical antivirals for herpes simplex keratitis are rarely needed for longer than 7–10&#160;days. Persistent disease despite topical antiviral therapy suggests misdiagnosis, medication toxicity, or immune dysfunction.</li>
			</ul>
			</p>
			</div>
			<p class="h1">Normal Ocular Flora</p>
		    <div id="Chapt9_Top2">
			<p class="body-text--no-indent-">Bacterial colonization of the eyelid margin and conjunctiva is normal and can be beneficial as long as normal flora competitively inhibit pathogenic strains. The spectrum of normal ocular flora varies with the age and geographic locale of the host. In the eye of an infant delivered vaginally, multiple bacterial species predominate, including <span class="italic">Staphylococcus aureus, Staphylococcus epidermidis,</span> streptococci, and <span class="italic">Escherichia col</span><span class="italic">i</span>; streptococci and pneumococci then predominate during the first 2&#160;decades of life. Although gram-&#173;negative bacteria are more commonly isolated with age, <span class="italic">S&#160;epidermidis</span> and other coagulase-&#173;negative staphylococci, <span class="italic">S&#160;aureus,</span> and diphtheroids remain some of the most common species identified from the external eye (<span class="xref-table">Table&#160;9-1</span>). Nonpathogenic colonization of the eyelid margin with <span class="italic">Demodex folliculorum</span> and <span class="italic">Demodex brevis</span> also becomes more common with age, and these parasites become almost ubiquitous over time. Any use of topical antibiotics or corticosteroids can alter the character and spectrum of eyelid and conjunctival flora.</p>
			<p class="reference-first">Fintelmann RE, Hoskins EN, Lietman TM, et al. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. <span class="italic">Arch Ophthalmol.</span> 2011;129(4):<br />399–402.</p>
			<p class="reference-mid">Graham JE, Moore JE, Jiru X, et al. Ocular pathogen or commensal: a PCR-&#173;based study of surface bacterial flora in normal and dry eyes. <span class="italic">Invest Ophthalmol Vis Sci.</span> 2007;48(12):<br />5616–5623.</p>
			<p class="reference-last--no-space-">Kemal M, Sümer Z, Toker MI, Erdoğan H, Topalkara A, Akbulut M. The prevalence of <span class="italic">Demodex folliculorum</span> in blepharitis patients and the normal population. <span class="italic">Ophthalmic Epidemiol.</span> 2005;12(4):287–290.</p>
			</div>
			<p class="h1">Pathogenesis of Ocular Infections</p>
		    <div id="Chapt9_Top3">
			<p class="body-text--no-indent-">Ocular infection can occur via <span class="italic">exogenous inoculation</span> or <span class="italic">hematogenous seeding,</span> which is rare. The initiation, severity, and characteristics of subsequent infection are influenced by the interplay between the virulence of the pathogen, the inoculum size, and the competence and nature of host defense mechanisms. Microbial virulence factors represent evolutionary adaptations by each microorganism that increase the organism’s odds of infection and survival. For example, highly virulent pathogens are more likely to cause infection than an equal number of less virulent pathogens; however, an infection may still result from either exposure, with the only difference being chance. The status of host defense mechanisms also determines the threshold of inoculum at which infection is more likely to occur. Compromised cells or organisms may not be able to avert infection as well as healthy cells or tissues (see Defense Mechanisms of the External Eye and Cornea in Chapter&#160;1).</p>
			<p class="body-text">In ocular surface infections acquired via exogenous inoculation, adherence of organisms to ocular surface epithelium is the first step. Many microorganisms express <span class="italic">adhesins,</span> proteins that bind with high affinity to host cell surface molecules, for example:</p>
			<ul>
				<li class="bullet-list-first"><span class="italic">Candida albicans</span> expresses surface proteins that mimic mammalian <span class="italic">integrins</span> (transmembrane proteins that mediate cell–cell and cell–extracellular matrix interactions).</li>
				<li class="bullet-list-mid">Viruses typically express surface proteins or glycoproteins that attach to constitutive cell surface molecules such as heparan sulfate (herpes simplex virus) or sialic acid (adenovirus).</li>
				<li class="bullet-list-last"><span class="italic">Acanthamoeba</span> trophozoites express a mannose-&#173;binding protein that attaches to surface epithelial cells.</li>
			</ul>
			<p class="body-text--no-indent-">Few organisms can invade an intact epithelium. Those that can include</p>
			<ul>
				<li class="bullet-list-first"><span class="italic">Neisseria gonorrhoeae</span></li>
				<li class="bullet-list-mid"><span class="italic">Neisseria meningitidis</span></li>
				<li class="bullet-list-mid"><span class="italic">Corynebacterium diphtheriae</span></li>
				<li class="bullet-list-mid"><span class="italic">Shigella</span> species</li>
				<li class="bullet-list-mid"><span class="italic">Haemophilus influenzae</span> biotype&#160;III (formerly <span class="italic">Haemophilus aegyptius</span>)</li>
				<li class="bullet-list-mid"><span class="italic">Listeria monocytogenes</span></li>
				<li class="bullet-list-last"><span class="italic">Fusarium species</span></li>
			</ul>
			<p class="body-text">Others must rely on a break in epithelial barrier function. For example, microbial proteases facilitate invasion by inducing cell lysis, degrading the extracellular matrix, and activating native corneal matrix–derived metalloproteinases (MMPs), triggering autodigestion. Bacterial exotoxins, such as those produced by streptococci, staphylococci, and <span class="italic">Pseudomonas aeruginosa,</span> can induce corneal cell necrosis. <span class="italic">Acanthamoeba</span> species and certain fungi secrete collagenases, whereas <span class="italic">P&#160;aeruginosa</span> elastase and alkaline protease destroy collagen and proteoglycan components of the cornea and degrade immunoglobulins, complement, interleukins, and other inflammatory cytokines. For viruses, adherence interactions facilitate invasion by the appropriation of host cell mechanisms.</p>
			<p class="body-text">Once adherent, some bacteria protect themselves from unfavorable elements of their physical environment, such as immunologic cells or antibacterial molecules in the tears, by the expression of exopolysaccharides organized into a <span class="italic">biofilm,</span> a 3-dimensional structure that allows interbacterial communication and signaling and interferes with phagocytosis. For viruses, evasion of the immune response involves multiple strategies.</p>
			<p class="body-text">Most organisms are eventually cleared from the site of an acute infection, but some persist in the host indefinitely. For example, following primary infection, herpes simplex virus and varicella-&#173;zoster virus establish latency in trigeminal ganglion cells. Chlamydial organisms survive and cause local chronic disease by persistence within intracellular phagosomes.</p>
			<p class="reference-first">McDougald D, Rice SA, Barraud N, Steinberg PD, Kjelleberg S. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. <span class="italic">Nat Rev Microbiol.</span> 2011;10(1):39–50.</p>
			<p class="reference-last--no-space-">Momburg F, Hengel H. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. <span class="italic">Curr Top Microbiol Immunol.</span> 2002;<br />269:57–74.</p>
			</div>
			<p class="h1">Ocular Microbiology</p>
			<div id="Chapt9_Top4">
			<p class="body-text--no-indent-">Of the many potentially pathogenic microorganisms capable of causing infectious external eye disease, those encountered most often are listed in <span class="xref-table">Table&#160;9-2</span>.</p>
			<p class="h2">Diagnostic Laboratory Techniques</p>
			<p class="body-text--no-indent-">The recent rise in the number of atypical ocular infections and the emergence of antibiotic-&#173;resistant strains have significantly increased the importance of specific microbiologic diagnosis. Interpretation of diagnostic specimens requires an understanding of the normal flora and cytology of the ocular surface. For optimal specimen collection, the appropriate materials should be available (<span class="xref-table">Tables&#160;9-3, 9-4</span>). See BCSC Section&#160;4, <span class="italic">Ophthalmic Pathology and Intraocular Tumors,</span> for additional discussion of specimen collection and handling, as well as laboratory evaluation for individual disease entities.</p>
			<p class="reference-single--no-space- ParaOverride-2">Thompson PP, Kowalski RP. A 13-year retrospective review of polymerase chain reaction testing for infectious agents from ocular samples. <span class="italic">Ophthalmology.</span> 2011;118(7):1449–1453.</p>
			<p class="h3">Specimen collection</p>
			<p class="h4-text ParaOverride-1"><span class="h4-head">Eyelid specimens</span> Eyelid vesicles or pustules may be opened with a sharp-&#173;pointed surgical blade or small-gauge needle. Material for cytology is smeared onto a glass slide and fixed in methanol or acetone for immunofluorescent staining. Collected vesicular fluid can be inoculated into a chilled viral transport medium for culture isolation in the laboratory. Microbial cultures are obtained by wiping the abnormal area with a broth-&#173;moistened swab, followed by direct inoculation of culture media. Culture of epilated eyelashes may be helpful in cases of chronic infection.</p>
			<p class="h4-text"><span class="h4-head">Conjunctival specimens</span> To minimize contamination of and inhibitory effects on organisms recovered, conjunctival swabbing for microbial specimens should be performed without topical anesthetic. For specimen collection, the clinician must debride enough conjunctival epithelial cells so that intracellular microbes can be seen on chemical stains. Calcium alginate or sterile Dacron swabs slightly moistened with thioglycollate broth are preferable to cotton-&#173;tipped swabs because the latter contain fatty acids, which may inhibit bacterial and viral growth. The swabbed material should be plated directly onto warmed solid media (blood, chocolate, and Sabouraud dextrose agar). The “nonhandled” distal end of the swab may then be broken off and placed directly into the remaining thioglycollate broth tube. If these media are not available, the specimens may be harvested with any standard culturette tube system that contains appropriate transport media.</p>
			<p class="body-text">When more conjunctival epithelial cells are desired, conjunctival scraping is the preferred method and reduces contamination from debris on the ocular surface. A local anesthetic is applied topically to the everted eyelid. Use of proparacaine hydrochloride 0.5% minimizes inhibition of organism recovery compared with tetracaine. A sterile spatula is scraped firmly across the tarsus; this should cause blanching but minimal bleeding. Alternatively, a cytobrush may be used to rub the conjunctiva, after which it is placed in a buffer solution to release the epithelial cells onto a Millipore filter. The cells are then fixed.</p>
			<p class="body-text">Appropriate instrumentation and proper handling are critical for specimens destined for polymerase chain reaction (PCR) testing, because any residual foreign DNA in the specimen may be detected by PCR. Conjunctival biopsy can be performed to help in the diagnosis of conditions such as Parinaud oculoglandular syndrome, mucous membrane pemphigoid, and human papillomavirus infection. See Chapter&#160;13 for a more detailed description of conjunctival biopsy.</p>
			<p class="h4-text"><span class="h4-head">Corneal specimens</span> A corneal culture is important to determine the etiology of large or sight-&#173;threatening ulcers, ulcers in which an atypical organism is suspected, or any ulcer that is not responding to therapy. A microbial specimen can be collected from a corneal ulcer by scraping the lesion with any of the following (with similar yields): platinum Kimura spatula, sterile needle, surgical blade, or thioglycollate-&#173;moistened calcium alginate or Dacron swab. For larger corneal ulcers (&gt;2&#160;mm), samples should be taken from several regions. A blade or spatula is preferable for preparing smears for chemical staining, but either a spatula or swab is acceptable for inoculation of culture media.</p>
			<p class="body-text">Specimens are best inoculated immediately onto microbiologic media that have been warmed to room temperature in anticipation of the culture procedure; microscopic slides should be prepared for Gram, Giemsa, or other special stains. To avoid contamination and false positives, care must be taken to avoid touching the blade or swab to the eyelids, fingers, or other nonsterile surface; in addition, a sterile instrument or swab should be used for each separate row of C-shaped streaks on each agar plate (<span class="xref-figure">Fig&#160;9-1</span>) and for each type of broth culture. For a viral culture, a Dacron swab is used to obtain virus-&#173;infected corneal or conjunctival cells; the swab is agitated in a chilled viral transport medium and then discarded. Calcium alginate and cotton swabs should be avoided, as both may inhibit viral recovery.</p>
			<p class="body-text">Corneal biopsy may be necessary in cases of apparent and significant microbial infection when repeated cultures from corneal scrapings are negative. See Chapter&#160;13.</p>
			<p class="body-text">In vivo confocal microscopy may be a helpful diagnostic and management tool with reasonable sensitivity and specificity for larger microorganisms such as <span class="italic">Acanthamoeba</span> and fungi.</p>
			<p class="reference-first">Alexandrakis G, Haimovici R, Miller D, Alfonso EC. Corneal biopsy in the management of progressive microbial keratitis. <span class="italic">Am&#160;J Ophthalmol.</span> 2000;129(5):571–576.</p>
			<p class="reference-mid">Kumar RL, Cruzat A, Hamrah P. Current state of in vivo confocal microscopy in management of microbial keratitis. <span class="italic">Semin Ophthalmol.</span> 2010;25(5–6):166–170.</p>
			<p class="reference-last--no-space-">Younger JR, Johnson RD, Holland GN, et al. Microbiologic and histopathologic assessment of corneal biopsies in the evaluation of microbial keratitis. <span class="italic">Am&#160;J Ophthalmol.</span> 2012;154(3):<br />512–519.e2.</p>
			<p class="h4-text"><span class="h4-head">Isolation techniques</span> For viral, chlamydial, and microsporidial infections, an appropriate tissue-&#173;culture cell line is selected for inoculation and examined for the development of cytopathic effects (CPEs) and cellular inclusions. For bacterial and fungal infections, directly inoculated blood, chocolate, and Sabouraud agars and thioglycollate broth are examined daily to detect visible growth. Microorganisms are studied by chemical staining, chemical reactions, and antimicrobial sensitivity testing. <span class="italic">Acanthamoeba</span> may be identified by the trails left by trophozoites on blood agar, but nonnutrient agar with an overlay of killed <span class="italic">Enterobacter aerogenes</span> is the optimal isolation medium.</p>
			<p class="h3 ParaOverride-3">Staining methods</p>
			<p class="body-text--no-indent-">See Table&#160;9-4 for recommended stains and culture media in the setting of suspected microbial keratitis.</p>
			</div>
			<p class="h1 ParaOverride-4">Virology and Viral Infections</p>
			<div id="Chapt9_Top5">
			<p class="body-text--no-indent-">Viruses are small (10–400&#160;nm in diameter) infectious units consisting of a single-&#173;stranded or double-&#173;stranded nucleic acid genome and a protein shell, or <span class="italic">capsid,</span> with or without an external lipid envelope. Viral nucleic acid consists of either RNA or DNA. RNA viral genome may be either single-&#173;stranded or double-&#173;stranded. Antiviral medications typically target viral gene transcription. Therefore, the clinical significance of the nucleic acid type lies principally in differences in susceptibility to antiviral medications.</p>
			<p class="body-text">The viral capsid interacts internally with the genome to stabilize it, protects the genome from the external environment, and, in the case of nonenveloped viruses, expresses on its surface the ligand for virus–host cell binding.</p>
			<p class="body-text">In some virus families, a host cell–derived lipid bilayer, or envelope, surrounds the protein capsid. Viral genome–encoded glycoproteins bound to the membrane act as ligands (antigens) for neutralizing antibodies directed against the virus. The lipid envelope is vulnerable to damage by ultraviolet (UV) light, detergents, alcohols, and general-&#173;use antiseptics. Because of this vulnerability, <span class="italic">enveloped viruses,</span> such as herpes simplex virus and human immunodeficiency virus (HIV), are intrinsically susceptible to the external environment, and their infectivity is short-lived outside the host. Enveloped viruses are difficult to transmit via fomites or medical instruments, and alcohol treatment of medical instrumentation is generally sufficient to prevent iatrogenic infection.</p>
			<p class="body-text">In contrast, <span class="italic">nonenveloped viruses,</span> such as adenoviruses, are relatively resistant to environmental insult and, in some cases, can persist for weeks outside the human host. To reduce the spread of such viruses in an office practice, the Centers for Disease Control and Prevention recommends the application of dilute bleach (1&#160;part household bleach [containing 5.25%–6.15% sodium hypochlorite] and 9&#160;parts water) to tonometer tips for at least 10&#160;minutes; however, care must be taken to clean residual bleach from the tonometer tip before use to prevent corneal toxicity. Alcohol sterilization is ineffective in this setting. For further discussion of infectious diseases, see BCSC Section&#160;1, <span class="italic">Update on General Medicine.</span></p>
			<p class="reference-first">King AMQ, Lefkowitz E, Adams MJ, Carstens EB. <span class="italic">Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses.</span> Oxford, UK: Elsevier; 2012.</p>
			<p class="reference-last--no-space-">Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008. Centers for Disease Control and Prevention website. www.cdc.gov/hicpac/disinfection_sterilization/6_0disinfection.html. Updated December&#160;29, 2009. Accessed January 31, 2017.</p>
			</div>			
			<p class="h1 ParaOverride-5">DNA Viruses: Herpesviruses</p>
			<div id="Chapt9_Top6">
			<p class="body-text--no-indent-">The structure of all herpesviruses includes a core of linear double-&#173;stranded DNA genome, surrounded by an icosahedral protein capsid, which is contained in an envelope studded with viral glycoproteins. Of the 8&#160;known human herpesviruses, those that affect the eye include herpes simplex virus types&#160;1 and 2 (HSV-1, HSV-2), varicella-&#173;zoster virus (VZV), Epstein-&#173;Barr virus (EBV), cytomegalovirus (CMV), and Kaposi sarcoma–associated herpesvirus (KSHV). All herpesviruses establish latency in their natural hosts, but the site of latency varies. For example, whereas HSV-1, HSV-2, and VZV establish latent infections in neurons of the sensory ganglia such as the trigeminal ganglion, EBV latency occurs in B&#160;lymphocytes.</p>
			<p class="h2 ParaOverride-6">Herpes Simplex Eye Diseases</p>
			<p class="body-text--no-indent-">Herpes simplex virus infection is ubiquitous in humans; at autopsy, nearly 100% of persons older than 60&#160;years are found to harbor HSV. Worldwide, most primary exposure to HSV occurs early in life, but in developing countries, primary exposure is increasingly delayed. It has been estimated that one-third of the world population experiences recurrent infection. HSV infections are, therefore, a large and worldwide public health problem.</p>
			<p class="h5-text ParaOverride-7"><span class="h5-head">pathogenesis</span> HSV-1 and HSV-2 are antigenically related. HSV-1 more commonly causes infection above the waist (orofacial and ocular infection) and HSV-2, below the waist (genital infection); but either virus can cause disease in either location. Primary infection with HSV-1 frequently manifests as a nonspecific upper respiratory tract infection and is recognized as HSV less than 5% of the time. In industrialized societies, 40%–80% of adults have serum antibodies to HSV-1, which represents a decline in infection from previous decades, and the age at which individuals undergo serologic conversion is increasing; HSV is now more commonly acquired in adolescence than in childhood. HSV infection is spread by direct contact with infected lesions or their secretions, most commonly as a result of exposure to viruses shed without clinical symptoms. HSV can be transmitted to the neonate during passage through the birth canal of a mother with active genital infection. In the newborn, HSV can cause systemic infection, including encephalitis, or disease confined to the skin and mucous membranes. BCSC Section&#160;6, <span class="italic">Pediatric Ophthalmology and Strabismus,</span> discusses neonatal herpes infection in greater detail.</p>
			<p class="body-text">HSV spreads from infected skin and mucosal epithelium via sensory nerve axons to establish latent infection in associated sensory nerve ganglia, most commonly the trigeminal ganglion. Latent infection of the trigeminal ganglion may occur in the absence of recognized primary infection, and reactivation of the virus may follow in any of the 3&#160;branches of cranial nerve&#160;V (ophthalmic nerve [V<span class="CharOverride-1">1</span>], maxillary nerve [V<span class="CharOverride-1">2</span>], and mandibular nerve [V<span class="CharOverride-1">3</span>]), despite primary disease in the area of innervation of 1&#160;particular branch. Approximately 0.15% of the US population has a history of external ocular HSV infection, and in approximately one-fifth of these individuals, stromal keratitis, the most common blinding manifestation of infection, develops.</p>
			<p class="reference-first">Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. <span class="italic">Cornea.</span> 2001;20(1):<br />1–13.</p>
			<p class="reference-last--no-space-">Pepose JS, Keadle TL, Morrison LA. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. <span class="italic">Am&#160;J Ophthalmol.</span> 2006;141(3):547–557.</p>
			<p class="h3 ParaOverride-8">Primary ocular infection</p>
			<p class="h5-text ParaOverride-1"><span class="h5-head">clinical presentation</span> Primary ocular HSV infection typically manifests as a blepharoconjunctivitis. The conjunctival inflammatory response is follicular and accompanied by a palpable preauricular lymph node. Vesicles on the skin (<span class="xref-figure">Fig&#160;9-2</span>) or eyelid margin (<span class="xref-figure">Fig&#160;9-3</span>) are important for diagnosis. Patients with primary ocular HSV infection can develop epithelial keratitis (<span class="xref-figure">Fig&#160;9-4</span>), but stromal keratitis and uveitis are uncommon.</p>
			<p class="body-text">Signs that can help the clinician distinguish acute primary ocular HSV infection from acute primary infection associated with adenovirus include the following:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-9">vesicles on the skin or eyelid margin or ulcers on the bulbar conjunctiva (HSV)</li>
				<li class="bullet-list-mid">dendritic epithelial keratitis (HSV)</li>
				<li class="bullet-list-last ParaOverride-10">conjunctival membranes or pseudomembranes (adenovirus)</li>
			</ul>
			<p class="body-text">Laterality is not a reliable distinguishing feature. Although adenoviral infections are more commonly bilateral, they can be unilateral, bilateral but asymmetric, or bilateral with delayed involvement of the second eye. Similarly, primary HSV infection may be either unilateral (most common) or bilateral.</p>
			<p class="h5-text"><span class="h5-head">laboratory evaluation</span> Demonstration of HSV is possible in productive epithelial infection with viral culture or antigen- or DNA-&#173;detection methodologies. Results of serologic tests for neutralizing or complement-&#173;fixing immunoglobulins may show a rising antibody titer during primary infection, but these tests are of no diagnostic assistance during recurrent episodes. As most adults are latently infected with HSV, serologic testing generally is helpful only when the results are negative.</p>
			<p class="body-text">Laboratory tests are indicated in complicated cases when the clinical diagnosis is uncertain and in all cases of suspected neonatal herpes infection. Vesicles can be opened with a needle, and vesicular fluid cultured. Scrapings from the vesicle base can be tested by cytology or for the presence of HSV antigen. Conjunctival scrapings or impression cytology specimens can be similarly analyzed by culture, antigen detection, or PCR.</p>
			<p class="h5-text"><span class="h5-head">management</span> Primary ocular HSV infection is a self-&#173;limited condition. Oral antiviral therapy speeds resolution of signs and symptoms. <span class="xref-table">Table&#160;9-5</span> summarizes the antiviral agents that are effective against ocular HSV infections. For discussion about their use, see the respective clinical syndromes below.</p>
			<p class="h3 ParaOverride-11">Recurrent ocular infection</p>
			<p class="h5-text ParaOverride-1"><span class="h5-head">pathogenesis</span> Recurrent HSV infection is caused by reactivation of the virus in a latently infected sensory ganglion, transport of the virus down the nerve axon to sensory nerve endings, and subsequent infection of ocular surface epithelia. HSV latency locally, in the cornea, as a cause of recurrent disease remains a controversial concept.</p>
			<p class="body-text">The concept of environmental factors (psychological stress, systemic infection, sunlight exposure, menstrual cycle, and contact lens wear) acting as triggers for the recurrence of HSV ocular disease was not confirmed by the Herpetic Eye Disease Study (HEDS), despite reports of UV light–induced reactivation of herpes labialis and keratitis. HSV keratitis recurs more frequently in patients with HIV infection, but the severity of the keratitis is equal to that occurring in immunocompetent persons.</p>
			<p class="reference-single--no-space- ParaOverride-7">Herpetic Eye Disease Study Group. Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. <span class="italic">Arch Ophthalmol.</span> 2000;118(12):<br />1617–1625.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Recurrent HSV infection can affect almost any ocular tissue, including the eyelid, conjunctiva, cornea, iris, uveal tract, trabecular meshwork, retina, and optic nerve, and it is typically unilateral, with only 3% of patients demonstrating bilateral disease (see Table&#160;9-7). The presence of bilateral disease should raise the possibility of immune dysfunction (eg, atopic dermatitis).</p>
			<p class="h4-text"><span class="h4-head">Blepharoconjunctivitis</span> Eyelid and/or conjunctival involvement can occur in patients with recurrent ocular HSV infection, although it may be clinically indistinguishable from primary infection. The condition is self-&#173;limited, but it can be treated with antiviral agents to shorten the course of illness and thus reduce the cornea’s exposure to infectious virus.</p>
			<p class="h4-text"><span class="h4-head">Epithelial keratitis</span> One of the most common presentations of clinically recognizable recurrent ocular HSV infection is epithelial keratitis.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Patients with epithelial keratitis report foreign-&#173;body sensation, light sensitivity, redness, and blurred vision. HSV infection of human corneal epithelium manifests as areas of punctate epithelial keratitis (<span class="xref-figure">Fig&#160;9-5</span>) that may coalesce into 1&#160;or more arborizing dendritic epithelial ulcers whose branches have terminal bulbs. The cytopathic swollen corneal epithelium at the edge of a herpetic ulcer stains with rose bengal (<span class="xref-figure">Fig&#160;9-6</span>) or lissamine green because of loss of cell membrane glycoproteins and subsequent lack of mucin binding by the cells. The bed of the ulcer stains with fluorescein (<span class="xref-figure">Fig&#160;9-7</span>) because of loss of cellular integrity and absence of intercellular tight junctions. Areas of dendritic keratitis may coalesce further, enlarging into a more expansive geographic epithelial ulcer (<span class="xref-figure">Fig&#160;9-8</span>; see also Fig&#160;9-7), particularly when topical corticosteroids are used.</p>
			<p class="body-text">Patients with HSV epithelial keratitis exhibit a ciliary flush and mild conjunctival injection. Mild stromal edema and subepithelial white blood cell infiltration may occur beneath the epithelial keratitis. Following resolution of dendritic epithelial keratitis, nonsuppurative subepithelial infiltration and scarring may be seen just beneath the area of prior epithelial ulceration, resulting in a ghost image, or ghost dendrite (<span class="xref-figure">Fig&#160;9-9</span>), which reflects the position and shape of the prior epithelial involvement.</p>
			<p class="body-text">Focal or diffuse reduction in corneal sensation occurs following HSV epithelial keratitis. The distribution of corneal hypoesthesia is related to the extent, duration, severity, and number of recurrences of herpetic keratitis. See Chapter&#160;4 for a more detailed description of neurotrophic keratopathy.</p>
			<p class="body-text">Dendritiform epithelial lesions may develop in various settings, including</p>
			<ul>
				<li class="bullet-list-first">VZV (see the discussion later in the chapter)</li>
				<li class="bullet-list-mid">adenovirus (uncommon)</li>
				<li class="bullet-list-mid">EBV (rare)</li>
				<li class="bullet-list-mid">epithelial regeneration line</li>
				<li class="bullet-list-mid">neurotrophic keratopathy (postherpetic, diabetes mellitus)</li>
				<li class="bullet-list-mid">soft contact lens wear (due to solutions containing thimerosal)</li>
				<li class="bullet-list-mid">topical medication use (antivirals, beta-&#173;blockers)</li>
				<li class="bullet-list-mid"><span class="italic">Acanthamoeba</span> epithelial keratitis</li>
				<li class="bullet-list-last ParaOverride-12">epithelial deposits (eg, iron lines, Fabry disease, tyrosinemia type&#160;II, systemic drug&#160;use)</li>
			</ul>
			<p class="h5-text"><span class="h5-head">laboratory evaluation</span> A specific clinical diagnosis of HSV as the cause of dendritic keratitis can usually be made based on the presence of characteristic clinical features. Multinucleated giant cells (nonspecific) and intranuclear inclusions (more specific of herpesviruses) may be seen on corneal scrapings. Tissue culture, antigen detection techniques (ELISA), and PCR may be helpful in establishing the diagnosis in atypical cases.</p>
			<p class="h5-text"><span class="h5-head">management</span> Most cases of HSV epithelial keratitis resolve spontaneously, and there is no clinical evidence to suggest that antiviral therapy influences the subsequent development of stromal keratitis or recurrent epithelial disease. However, treatment shortens the clinical course and might conceivably reduce the magnitude of any associated herpetic neuropathy, subepithelial scarring, or the potential risk of immune-&#173;mediated diseases of the cornea. Antiviral therapy can be used alone or in combination with epithelial debridement. Trifluridine 1% solution 8&#160;times daily is efficacious for both dendritic and geographic epithelial keratitis. Ganciclovir 0.15% gel seems to have similar efficacy to topical acyclovir but is less toxic to the ocular surface than is trifluridine. Acyclovir 3% ophthalmic ointment has been reported to be as effective as and less toxic than trifluridine and vidarabine, but the ophthalmic form is not available in the United States at this time except through specialty compounding pharmacies. Treatment of the disease with topical antivirals generally should be discontinued within 10–14&#160;days to avoid unnecessary toxicity to the ocular surface. Gentle epithelial debridement with a dry cotton-&#173;tipped applicator or cellulose sponge speeds resolution and may be helpful as adjunctive therapy in drug-&#173;resistant HSV keratitis.</p>
			<p class="body-text">Oral acyclovir has been reported to be as effective as topical antivirals for the treatment of epithelial keratitis and does not cause ocular toxicity. For this reason, oral therapy is preferred by an increasing number of physicians. Valacyclovir, a prodrug of acyclovir, is just as effective for ocular HSV disease but can cause thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in severely immunocompromised patients such as those with AIDS; thus, it must be used with caution if the patient’s liver function is compromised or the immune status is unknown. Alternative systemic antiviral drugs are listed in Table&#160;9-5.</p>
			<p class="body-text">As previously noted, topical corticosteroids are contraindicated in the presence of active herpetic epithelial keratitis; patients with this disease who are using systemic corticosteroids for other indications should be treated aggressively with systemic antiviral therapy.</p>
			<p class="h4-text"><span class="h4-head">Stromal keratitis</span> HSV stromal keratitis is the most common cause of infectious corneal blindness in the United States, and it is the form of recurrent herpetic external disease associated with the greatest visual morbidity. Stromal involvement results from immunologic activity generated by the host against the virus. Each episode of active stromal keratitis increases the risk of future episodes.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> <span class="italic">Herpetic stromal keratitis</span> can be nonnecrotizing (interstitial or disciform) or necrotizing, and different forms may present simultaneously. <span class="italic">Herpetic interstitial keratitis</span> presents as unifocal or multifocal interstitial haze or whitening of the stroma in the absence of epithelial ulceration (<span class="xref-figure">Fig&#160;9-10</span>). Mild stromal edema may accompany the haze, but epithelial edema is not typical. In the absence of significant extracorneal inflammatory signs such as conjunctival injection or anterior chamber cells, it may be difficult to identify active disease in an area of previous scarring and thinning. Long-&#173;standing or recurrent HSV interstitial keratitis may be associated with corneal vascularization. The differential diagnosis of herpetic interstitial keratitis includes</p>
			<ul>
				<li class="bullet-list-first ParaOverride-13">VZV keratitis</li>
				<li class="bullet-list-mid"><span class="italic">Acanthamoeba</span> keratitis</li>
				<li class="bullet-list-mid">syphilis</li>
				<li class="bullet-list-mid">EBV keratitis</li>
				<li class="bullet-list-mid">mumps keratitis</li>
				<li class="bullet-list-mid">Lyme disease</li>
				<li class="bullet-list-mid">sarcoidosis</li>
				<li class="bullet-list-mid">Cogan syndrome</li>
				<li class="bullet-list-mid">atopic keratitis</li>
				<li class="bullet-list-last ParaOverride-14">vernal keratitis</li>
			</ul>
			<p class="body-text"><span class="italic">Herpetic disciform keratitis</span> is a primary endotheliitis, which presents as corneal stromal and epithelial edema in a round or oval distribution, associated with keratic precipitates underlying the zone of edema (<span class="xref-figure">Fig&#160;9-11</span>). Iridocyclitis can be associated, and the disciform keratitis may be confused with uveitis with secondary corneal endothelial decompensation. However, in disciform keratitis, disc-shaped stromal edema and keratic precipitates appear out of proportion to the degree of anterior chamber reaction. Disciform keratitis due to HSV and that due to VZV are clinically indistinguishable.</p>
			<p class="body-text"><span class="italic">Necrotizing herpetic keratitis</span> appears as suppurative corneal inflammation (<span class="xref-figure">Fig&#160;9-12</span>). It may be severe, progress rapidly, and appear clinically indistinguishable from fulminant bacterial or fungal keratitis. Overlying epithelial ulceration is common, but the epithelial defect may occur somewhat eccentric to the infiltrate, and the edges of the epithelial ulcer do not stain with rose bengal dye. Corneal stromal vascularization is common. The differential diagnosis for necrotizing herpetic keratitis includes microbial keratitis due to bacteria, fungi, or <span class="italic">acanthamoebae;</span> retained foreign body; and topical anesthetic abuse.</p>
			<p class="reference-first ParaOverride-15">Farooq AV, Shukla D. Corneal latency and transmission of herpes simplex virus-1. <span class="italic">Future Virol.</span> 2011;6(1):101–108.</p>
			<p class="reference-mid">Kip KE, Cohen F, Cole SR, et al; Herpetic Eye Disease Study Group. Recall bias in a prospective cohort study of acute time-&#173;varying exposures: example from the Herpetic Eye Disease Study. <span class="italic">J&#160;Clin Epidemiol.</span> 2001;54(5):482–487.</p>
			<p class="reference-mid">Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. <span class="italic">Cornea.</span> 2001;20(1):<br />1–13.</p>
			<p class="reference-last--no-space-">Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976–2007: the effect of oral antiviral prophylaxis. <span class="italic">Arch Ophthalmol.</span> 2010;128(9):1178–1183.</p>
			<p class="h5-text"><span class="h5-head">management</span> Many past controversies regarding the optimal management of HSV stromal keratitis have been resolved by the landmark HEDS (<span class="xref-table">Table&#160;9-6</span>). Most important, HEDS findings showed that topical corticosteroids given with a prophylactic antiviral reduce persistence or progression of stromal inflammation and shorten the duration of HSV stromal keratitis; in addition, long-term suppressive oral acyclovir therapy reduces the rate of recurrent HSV keratitis and helps preserve vision. Lifelong antiviral prophylaxis is recommended for patients with multiple recurrences of HSV stromal keratitis.</p>
			<p class="body-text">The experimental protocol applied by HEDS investigators for patients with herpetic stromal keratitis is a useful starting point for a treatment algorithm. Visually significant herpetic interstitial keratitis is treated initially with prednisolone 1% drops every 2&#160;hours, accompanied by a prophylactic antiviral drug, either topical trifluridine 4&#160;times daily or an oral agent such as acyclovir 400&#160;mg twice daily or valacyclovir 500&#160;mg once a day. The prednisolone drops are tapered every 1–2&#160;weeks depending on the degree of clinical improvement. The antiviral is given to prevent severe epithelial keratitis should the patient shed HSV while using corticosteroid drops, and it is generally continued until the patient has completely stopped the corticosteroids or is using less than 1&#160;drop of prednisolone 1% per day. The corticosteroid should be tapered to the lowest possible dosage that controls the patient’s inflammation.</p>
			<p class="body-text">Currently available topical antiviral medications are not absorbed by the cornea through an intact epithelium, but orally administered acyclovir penetrates an intact cornea and anterior chamber. In this context, anecdotal evidence suggests that oral acyclovir might benefit the deep corneal inflammation of disciform keratitis. The HEDS showed no additional benefit when acyclovir was added to trifluridine and prednisolone for the treatment of herpetic stromal keratitis, but disciform keratitis was not analyzed as a separate group. Some cornea specialists routinely substitute oral acyclovir for topical trifluridine in treating disciform keratitis.</p>
			<p class="body-text">Necrotizing stromal keratitis is probably the least common but most destructive form of herpetic keratitis. The diagnosis is frequently one of exclusion following negative cultures for fungal and bacterial pathogens, but it is suggested by a history of facial, conjunctival, and/or corneal HSV infection. The toxicity of topical antiviral agents may be undesirable in patients with necrotizing inflammation and can confuse the clinical picture. Therefore, an oral antiviral such as acyclovir is preferred. Fortunately, necrotizing herpetic keratitis seems to be very sensitive to topical corticosteroids, and twice-a-day dosing may be sufficient to control inflammation in many patients.</p>
			<p class="h4-text"><span class="h4-head">Iridocyclitis</span> Granulomatous or nongranulomatous iridocyclitis may accompany necrotizing stromal keratitis or occur independently of corneal disease. Elevated intraocular pressure (IOP) caused by trabeculitis and/or patchy iris transillumination defects may be found in patients with HSV iridocyclitis. Infectious virus has been cultured from the anterior chamber of such patients and its presence positively correlated with ocular hypertension. Therefore, the diagnosis of HSV iridocyclitis is suggested by a unilateral presentation associated with an elevated IOP with or without focal iris transillumination defects. A history or clinical evidence of prior HSV ocular disease is suggestive. One HEDS trial suggested a statistical trend toward the benefit of oral acyclovir (400&#160;mg, 5&#160;times daily) in treating HSV iridocyclitis in patients also receiving topical corticosteroids, but the number of patients recruited was too small to achieve statistically conclusive results.</p>
			<p class="body-text">See BCSC Section&#160;1, <span class="italic">Update on General Medicine,</span> for additional discussion of viral therapeutics, and Section&#160;2, <span class="italic">Fundamentals and Principles of Ophthalmology,</span> for discussion of specific antiviral agents.</p>
			<p class="reference-first ParaOverride-15">Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. <span class="italic">Ophthalmology.</span> 1994;101(12):1871–1882.</p>
			<p class="reference-mid">Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. <span class="italic">Arch Ophthalmol.</span> 1996;114(9):1065–1072.</p>
			<p class="reference-mid">Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. <span class="italic">Arch Ophthalmol.</span> 1997;115(6):703–712.</p>
			<p class="reference-mid">Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. <span class="italic">N Engl J Med.</span> 1998;339(5):300–306.</p>
			<p class="reference-mid">Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. <span class="italic">Arch Ophthalmol.</span> 2000;118(8):<br />1030–1036.</p>
			<p class="reference-last--no-space-">Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. <span class="italic">Ophthalmology.</span> 1994;101(12):<br />1883–1895.</p>
			<p class="h3">Complications of herpetic eye disease</p>
			<p class="body-text--no-indent-">Complications of herpetic eye disease affect all layers of the cornea. <span class="italic">Epitheliopathy</span> is common when topical antiviral treatment is prolonged, and its severity and duration are directly related to the duration of antiviral use. Topical antiviral toxicity presents most commonly as diffuse punctate corneal epithelial erosions with conjunctival injection. Limbal stem cell deficiency may result either from recurrent infection and inflammation or from the frequent use of many of the topical antiviral drugs. <span class="italic">Neurotrophic keratopathy</span> may develop in patients with reduced corneal sensation secondary to previous herpetic infection. (See the section Neurotrophic Keratopathy and Persistent Corneal Epithelial Defects in Chapter&#160;4.) Punctate epithelial erosions, sometimes with a vortex pattern of punctate fluorescein staining, chronic epithelial regeneration lines, and frank neurotrophic ulcers, characterize neurotrophic keratopathy. These ulcers can be distinguished from herpetic epithelial keratitis by a relative absence of rose bengal staining. Neurotrophic ulcers (see Chapter&#160;4, Fig&#160;4-1) are typically round or oval and located in the central, inferior, or inferonasal cornea. Corneal epithelium at the edges of a neurotrophic ulcer may appear to roll under itself and typically has a gray, elevated appearance. Liberal use of nonpreserved lubricating drops, gels, and ointments; autologous serum; and punctal occlusion are the mainstays of therapy. To prevent progressive stromal thinning and perforation, tarsorrhaphy and/or amniotic membrane application, either surgical or self-&#173;retaining, is indicated for neurotrophic ulcers that fail to respond to conservative therapy. On occasion, active or resolving interstitial stromal keratitis due to HSV is associated with a chronic epithelial defect that does not stain with rose bengal. This so-called <span class="italic">metaherpetic ulcer</span> probably results from neurotrophic mechanisms or a devitalized corneal stroma.</p>
			<p class="body-text">Severe or long-&#173;standing disciform keratitis can result in <span class="italic">persistent bullous keratopathy.</span> Stromal inflammation in general, whether interstitial or necrotizing, commonly leads to permanent corneal scarring and irregular astigmatism. Both scarring and astigmatism may improve with time in some patients. Fitting with a gas-&#173;permeable contact lens usually improves vision beyond that achieved with spectacle refraction. In patients with deep corneal stromal vascularization due to prior necrotizing herpetic inflammation, secondary lipid keratopathy may further impair the vision. Topical corticosteroids may suppress new vessel growth and halt additional lipid deposition.</p>
			<p class="h3">Surgical treatment</p>
			<p class="body-text--no-indent-">Penetrating keratoplasty (PK) or deep anterior lamellar keratoplasty (DALK) is indicated in selected patients with visually significant stromal scarring not correctable with a spectacle or contact lens. Oral antiviral therapy may improve graft survival by reducing the risk of HSV recurrence and allow more liberal use of topical corticosteroids. Oral antiviral agents are not toxic to the corneal epithelium and are therefore generally preferable to topical antivirals in patients after PK. Optical PK is successful in nearly 80% of cases when performed in eyes without signs of active inflammation for at least 6&#160;months prior to surgery. See Chapter&#160;15 for additional discussion of PK and DALK. Tectonic surgery is indicated in eyes with impending or frank corneal perforation due to necrotizing or neurotrophic ulcers, although stromal inflammation and ulceration may develop and graft failure may occur in inflamed herpetic eyes. Therefore, small descemetoceles and perforations in inflamed eyes may best be treated by applying therapeutic tissue adhesive and a bandage contact lens and delaying surgery until inflammation can be controlled. Amniotic membrane transplantation or conjunctival flaps may also be used for persistent epithelial defects with and without corneal thinning. Keratoprostheses may have an important role because of the risk of rejection and recurrence in HSV corneal disease.</p>
			<p class="h2 ParaOverride-16">Varicella-Zoster Virus Dermatoblepharitis, Conjunctivitis, and Keratitis</p>
			<p class="body-text--no-indent-">As with other herpesviruses, VZV causes a primary infection (varicella, or chickenpox) and establishes a subsequent latent infection, occasionally followed later by recurrent disease (zoster, or shingles, discussed later). VZV infection of childhood, now uncommon in countries with widespread HZV vaccination programs, is usually a self-&#173;limited infection rarely associated with long-term sequelae. However, infection of adults or immunosuppressed individuals can be fatal. In children, VZV infection manifests with fever, malaise, and a vesicular dermatitis that lasts 7–10&#160;days. Except for eyelid vesicles and follicular conjunctivitis, ocular involvement is uncommon during primary infection. VZV infection, whether primary or recurrent, can usually be distinguished from HSV infection through a careful history and examination. Distinguishing features of each infection are listed in <span class="xref-table">Table&#160;9-7</span>.</p>
			<p class="h5-text ParaOverride-8"><span class="h5-head">pathogenesis</span> Primary VZV infection occurs upon direct contact with VZV skin lesions or respiratory secretions via airborne droplets and is highly contagious for naive individuals. As with HSV, the site of VZV latency is the sensory ganglia and, in approximately 20% of infected individuals, the virus reactivates later. Of all cases with zoster, 15% involve the cranial nerve (CN) V, or the trigeminal nerve; see “Herpes zoster ophthalmicus” later in this chapter.</p>
			<p class="h5-text ParaOverride-7"><span class="h5-head">clinical presentation</span> The rash of chickenpox begins as macules and progresses to papules, vesicles, and then pustules that dry, crust over, and may leave individual scars. Ocular involvement may include follicular conjunctivitis, occasionally associated with a vesicular lesion on the bulbar conjunctiva or eyelid margins. Punctate or dendritic epithelial keratitis is uncommon. Although subepithelial infiltrates, microdendritic keratitis, stromal keratitis, disciform keratitis, uveitis, and elevated IOP are rare, recurrent varicella keratouveitis may cause significant morbidity in some patients.</p>
			<p class="h5-text ParaOverride-7"><span class="h5-head">laboratory evaluation</span> Laboratory confirmation of acute or recurrent VZV infection is possible by immunodiagnostic methods, viral culture, and PCR. Serologic testing is used primarily to identify varicella-&#173;naive adults who might benefit from prophylactic vaccination. As with HSV, scrapings from the base of a vesicle can be tested by cytology, PCR, or culture, or for the presence of VZV antigen. Conjunctival scrapings or corneal impression cytology specimens can be similarly analyzed by culture, antigen detection, or PCR.</p>
			<p class="h5-text ParaOverride-7"><span class="h5-head">management</span> Because infected individuals shed the virus in respiratory secretions before the onset of the characteristic rash, avoiding infected persons is not always possible. Vaccination against varicella is recommended for anyone older than 12&#160;months without a history of chickenpox or with a negative serologic test result. The severity of signs and symptoms may be reduced in clinically ill patients by the administration of oral acyclovir. Significant keratitis or uveitis can be treated with topical corticosteroids.</p>
			<p class="h3 ParaOverride-8">Herpes zoster ophthalmicus</p>
			<p class="h5-text ParaOverride-1"><span class="h5-head">pathogenesis</span> Following primary infection, VZV establishes latency in sensory ganglia. Zoster (shingles) represents endogenous reactivation of latent virus in individuals with a waning level of immunity to infection. Most patients with zoster are in their sixth to ninth decades of life, and the majority are healthy, with no specific predisposing factors. However, zoster is more common in patients on immunosuppressive therapy; in those with a systemic malignancy, a debilitating disease, or HIV infection; and after major surgery, trauma, or radiation therapy. Herpes zoster in otherwise healthy children has been described in the literature.</p>
			<p class="h5-text ParaOverride-7"><span class="h5-head">clinical presentation</span> Zoster manifests as a painful vesicular dermatitis typically localized to a single dermatome on the thorax or face. Initially, affected patients may report fever and malaise and experience warmth, redness, and increased sensation in the affected dermatome. The most commonly affected dermatomes are on the thorax (T3 through L3) and those supplied by CN&#160;V. The ophthalmic division of the trigeminal nerve is affected more often than the maxillary and mandibular branches, and its involvement is referred to as <span class="italic">herpes zoster ophthalmicus (HZO)</span> (<span class="xref-figure">Fig&#160;9-13</span>). A maculopapular rash, followed by vesicles and then pustules, is characteristic. Zoster dermatitis may result in large scabs that resolve slowly and leave significant scarring. Neurotrophic keratopathy and sectoral iris atrophy are characteristic. Inflammation of almost any ocular tissue can occur and recur in HZO.</p>
			<p class="body-text">Zoster dermatitis is accompanied by pain and dysesthesia. The pain usually decreases as lesions resolve; however, neuralgia in the affected dermatome can continue for months to years. The severity of pain ranges from mild to incapacitating. Ocular involvement occurs in more than 70% of patients with zoster of the first division of CN&#160;V and may appear in association with any branch, including the nasociliary, frontal, or lacrimal branches. Ophthalmic complications also may occur with zoster of the second (maxillary) division of CN&#160;V. In immunosuppressed patients, zoster may involve more than 1&#160;branch of the trigeminal nerve at the same time; after reactivation, disease may be chronic, and there may be multiple recurrences. See BCSC Section&#160;2, <span class="italic">Fundamentals and Principles of Ophthalmology,</span> for discussion of the innervation of the eye and face.</p>
			<p class="body-text">Eyelid vesicular eruption can lead to secondary bacterial infection, eyelid scarring, marginal notching, loss of cilia, trichiasis, and cicatricial entropion or ectropion. Scarring and occlusion of the lacrimal puncta or canaliculi may occur. Episcleritis or scleritis associated with zoster may be nodular, zonal, or diffuse.</p>
			<p class="body-text">Both punctate and dendritic epithelial keratitis caused by viral replication in corneal epithelium are common manifestations of ophthalmic zoster. Herpes zoster pseudodendrites (distinguished from the true dendrites of HSV corneal disease, which have a central epithelial ulceration) form branching or “medusa-&#173;like” lesions that resemble raised mucous plaques, stain minimally with fluorescein and rose bengal, and have blunt rather than bulbous ends. The elevated dendritiform mucous plaques may occur on the cornea weeks to months after resolution of the skin lesions. These may be chronically culture-&#173;positive for VZV in patients with AIDS. Diminished corneal sensation occurs in up to 50% of patients. Nummular corneal infiltrates are said to be characteristic of zoster stromal keratitis (<span class="xref-figure">Fig&#160;9-14</span>), but the interstitial keratitis, disciform keratitis, and anterior uveitis with increased IOP in HZO are clinically indistinguishable from those caused by HSV infection. Chronic corneal stromal inflammation can lead to corneal vascularization, lipid keratopathy (<span class="xref-figure">Fig&#160;9-15</span>), and corneal opacity. Corneal anesthesia may be profound, and neurotrophic keratopathy due to HZO can be extremely difficult to manage.</p>
			<p class="body-text">Focal choroiditis, occlusive retinal vasculitis, and retinal detachment have been reported. Ipsilateral acute retinal necrosis (ARN) temporally associated with HZO is uncommon.</p>
			<p class="body-text">Orbital or central nervous system involvement as a result of an occlusive arteritis may lead to eyelid ptosis, orbital edema, and proptosis. Papillitis or retrobulbar optic neuritis may also develop. Cranial nerve palsies, when meticulously investigated, have been reported to occur in up to one-third of cases of HZO, with CN&#160;III (oculomotor) most commonly affected. Cranial nerve involvement may occur within the orbit or the cavernous sinus. Systemic dissemination is unusual in immunocompetent patients but can occur in up to 25% of those who are immunocompromised.</p>
			<p class="h5-text"><span class="h5-head">management</span> A varicella-&#173;zoster vaccine was approved by the US Food and Drug Administration (FDA) after testing in 38,000&#160;patients showed a 50% reduction in incidence of zoster and a 66% reduction in postherpetic neuralgia (PHN). This live, attenuated vaccine is similar to the childhood vaccine but contains a higher dose of the vaccine virus. In the United States, the vaccine is recommended for immunocompetent individuals aged 60&#160;years and older but was recently made available to those aged 50&#160;years and older. Recent studies indicate, however, that the incidence of herpes zoster rises with increasing age, starting from age 50&#160;years, suggesting that the vaccine should be recommended for persons younger than 60&#160;years. There is concern that the average age at infection with herpes zoster will become significantly lower with the widespread use of both vaccines and the consequential reduction in exposure to virus-&#173;shedding individuals, who inadvertently boost community immunity. This would most likely affect persons aged 20–50&#160;years—those not currently covered by the vaccines—and could eventually lead to a change in age indications. There are currently no clear recommendations concerning the use of the adult vaccine in patients with previous HZO, but the potential to reactivate or exacerbate HZO-&#173;related inflammation exists, as such cases have been reported. It is suggested that vaccinations be administered during an extensive quiet period.</p>
			<p class="body-text">Oral antiviral therapy for HZO was found in randomized clinical trials to reduce viral shedding from vesicular skin lesions, reduce the chance of systemic dissemination of the virus, and decrease the incidence and severity of the most common ocular complications. Oral antiviral therapy may reduce the duration and severity if not the incidence of PHN, if begun within 72&#160;hours of the onset of symptoms. There are also reports to suggest that initiating antiviral therapy after 72&#160;hours, especially in the presence of new vesicles, is beneficial.</p>
			<p class="body-text">The current recommendation for HZO is oral famciclovir 500&#160;mg 3&#160;times per day, valacyclovir 1&#160;g 3&#160;times per day, or acyclovir 800&#160;mg 5&#160;times per day for 7–10&#160;days, best if started within 72&#160;hours of the onset of skin lesions. Topical antiviral medications are not effective, except in the treatment of corneal epithelial mucoid plaques or more chronic epithelial disease. Intravenous acyclovir therapy (10&#160;mg/kg every 8&#160;hours) is indicated in patients at risk for disseminated zoster due to immunosuppression. Cutaneous lesions may be treated with moist warm compresses and topical antibiotic ointment. Topical corticosteroids and cycloplegics are indicated for keratouveitis. Oral corticosteroids, used with a tapering dosage, are recommended by some for treating patients older than 60&#160;years with HZO to reduce the pain associated with early zoster and facilitate a rapid return to a normal quality of life. However, the use of oral corticosteroids is controversial; their use does not seem to affect the incidence or duration of PHN.</p>
			<p class="body-text">Postherpetic neuralgia may respond to capsaicin cream applied to the involved skin, but low doses of amitriptyline, desipramine, clomipramine, or carbamazepine may be necessary to control severe symptoms. Gabapentin and pregabalin have been shown to be efficacious in managing PHN. Aggressive lubrication with nonpreserved artificial tears, gels, or ointments, combined with punctal occlusion and tarsorrhaphy as necessary, may be indicated for neurotrophic keratopathy. For a patient with significant pain, early referral to a pain management specialist should be considered.</p>
			<p class="reference-first ParaOverride-7">Liesegang TJ. Herpes zoster ophthalmicus: natural history, risk factors, clinical presentation, and morbidity. <span class="italic">Ophthalmology.</span> 2008;115(2 Suppl):S3–S12.</p>
			<p class="reference-mid">Liesegang TJ. Varicella-&#173;zoster virus vaccines: effective, but concerns linger. <span class="italic">Can&#160;J Ophthalmol.</span> 2009;44(4):379–384.</p>
			<p class="reference-mid">Oxman MN, Levin MJ, Johnson GR, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. <span class="italic">N&#160;Engl J&#160;Med.</span> 2005;<br />352(22):2271–2284.</p>
			<p class="reference-last--no-space-">Schmader KE, Levin MJ, Gnann JW Jr, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59&#160;years. <span class="italic">Clin Infect Dis.</span> 2012;54(7):922–928.</p>
			<p class="h2 ParaOverride-6">Epstein-Barr Virus Dacryoadenitis, Conjunctivitis, and Keratitis</p>
			<p class="h5-text ParaOverride-1"><span class="h5-head">pathogenesis</span> Epstein-&#173;Barr virus (EBV) is a ubiquitous herpesvirus that infects most humans by early adulthood. Spread of EBV occurs by the sharing of saliva, and the virus results in subclinical infection in the first decade of life; if acquired later in life, it causes infectious mononucleosis. The virus remains latent in B&#160;lymphocytes and pharyngeal mucosal epithelial cells throughout life. Ocular disease is uncommon.</p>
			<p class="h5-text ParaOverride-8"><span class="h5-head">clinical presentation</span> Epstein-&#173;Barr virus is the most common cause of acute dacryoadenitis, characterized by inflammatory enlargement of 1 or both lacrimal glands. Acute follicular conjunctivitis, Parinaud oculoglandular syndrome, and bulbar conjunctival nodules have been reported in patients with acute infectious mononucleosis and may be the result of EBV infection. There are 3&#160;principal forms of EBV stromal keratitis; the diagnosis is made on the basis of a history of recent infectious mononucleosis and/or persistently high EBV serologic titers:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-17">Type 1: multifocal subepithelial infiltrates that resemble adenoviral keratitis</li>
				<li class="bullet-list-mid">Type 2: multifocal, blotchy, pleomorphic infiltrates with active inflammation (<span class="xref-figure">Fig</span><span class="xref-figure">&#160;</span><span class="xref-figure">9-16</span>) or granular ring-shaped opacities (inactive form) in anterior to midstroma</li>
				<li class="bullet-list-last ParaOverride-18">Type 3: multifocal deep or full-&#173;thickness peripheral infiltrates, with or without vascularization, that resemble interstitial keratitis due to syphilis</li>
			</ul>
			<p class="body-text--no-indent-">EBV-&#173;associated keratitis may be unilateral or bilateral and may, in select cases, appear similar to the interstitial keratitis induced by HSV, VZV, Lyme disease, adenovirus, or syphilis. As EBV is rare, clinical suspicion for it is usually low; EBV should be considered in patients with disease refractory to conventional antiviral treatment.</p>
			<p class="h5-text"><span class="h5-head">diagnosis and management</span> Because it is difficult to isolate the virus, the diagnosis of EBV infection depends on the detection of antibodies to various viral components. During acute infection, first immunoglobulin&#160;(Ig) M and then IgG antibodies to viral capsid antigens (VCAs) appear. Anti-VCA IgG may persist for the life of the patient. There is an increase in the level of antibodies to early antigens during the acute phases of the disease and a subsequent decrease to low or undetectable levels in most individuals. Antibodies to EBV nuclear antigens appear weeks to months later, providing serologic evidence of past infection. Acyclovir is not an effective treatment for the clinical signs and symptoms of infectious mononucleosis, but the impact of antiviral therapy on the corneal manifestations of EBV infection remains unknown. Corticosteroids may be effective in patients with reduced vision due to apparent EBV stromal keratitis, but they should not be administered without a prophylactic antiviral if HSV infection is a possibility.</p>
			<p class="reference-single--no-space- ParaOverride-2">Chodosh J. Epstein-&#173;Barr virus stromal keratitis. <span class="italic">Ophthalmol Clin North Am.</span> 1994;7(4):<br />549–556.</p>
			<p class="h2 ParaOverride-6">Cytomegalovirus Keratitis and Anterior Uveitis</p>
			<p class="h5-text ParaOverride-1"><span class="h5-head">pathogenesis</span> Cytomegalovirus (CMV) is a ubiquitous herpesvirus that infects over 90% of humans by 80&#160;years of age. Spread of CMV occurs through the sharing of saliva, ingestion of breast milk, or sexual contact. CMV causes subclinical infection in children and a nonspecific febrile illness lasting 1–3&#160;weeks in adults. A viremia transmits the virus to the bone marrow, where it becomes latent in CD34<span class="CharOverride-2">+</span> myeloid progenitor cells until these cells are activated, which allows expression and shedding of the virus.</p>
			<p class="h5-text ParaOverride-19"><span class="h5-head">clinical presentation</span> Cytomegalovirus has been most commonly associated with a sectoral, necrotizing retinitis that is seen almost exclusively in AIDS and other immunocompromised states. Few anterior segment complications were previously associated with CMV retinitis, with the exception of thin stellate keratic precipitates. In rare cases, epithelial and stromal CMV keratitis have been described, usually when CMV infection was undiagnosed prior to keratoplasty. However, CMV has been increasingly identified as a significant cause of anterior uveitis and corneal endotheliitis (<span class="xref-figure">Fig&#160;9-17</span>). This is probably due, in part, to improved diagnostic acumen. The anterior uveitis is characterized by an acute or chronic iritis, with moderate to severe rises in IOP that are variably responsive to topical corticosteroids. The addition of keratic precipitates, endothelial cell loss, and diffuse or local corneal edema suggests CMV endotheliitis. These presentations are often misdiagnosed as HSV-&#173;related endotheliitis, trabeculitis, or Posner-&#173;Schlossman syndrome and can be distinguished only by their response to therapy and by results of laboratory investigation.</p>
			<p class="h5-text"><span class="h5-head">laboratory evaluation</span> Laboratory confirmation of CMV-&#173;associated anterior segment disease is usually accomplished through PCR testing of aqueous humor for CMV. Aqueous humor is obtained by an anterior chamber tap, which must be performed during an episode of active disease for greatest yield. Concurrent serum testing should also be performed to rule out a systemic viremia as a cause of intraocular detection. In addition, concomitant testing for other herpesviruses can be performed. CMV-&#173;associated anterior segment disease may also be diagnosed through histologic examination of corneal biopsy or surgical specimens.</p>
			<p class="h5-text"><span class="h5-head">management</span> Cytomegalovirus-&#173;associated anterior segment disease is treated with ganciclovir and is not responsive to famciclovir, acyclovir, or its derivatives. Resistance of a presumed HSV infection to these agents should raise suspicion for CMV. The optimal treatment of CMV-&#173;associated anterior segment disease is unknown, but treatment with oral valganciclovir 900&#160;mg twice daily (with the possibility of lower maintenance dosing) is effective. Valganciclovir may be poorly tolerated and, unfortunately, recurrence of disease with withdrawal of the medication is common. Alternatives include ganciclovir implants and topical ganciclovir, which has demonstrated therapeutic effects when used as an adjunct to systemic therapy and when used in a maintenance role. Recurrence is possible after keratoplasty. The role of corticosteroids is unclear, as there is some suggestion that corticosteroid use may prolong or worsen CMV-&#173;associated anterior segment disease. Corticosteroids should therefore be used judiciously in this setting.</p>
			<p class="reference-first">Carmichael A. Cytomegalovirus and the eye. <span class="italic">Eye (Lond).</span> 2012;26(2):237–240.</p>
			<p class="reference-mid">Chan AS, Mehta JS, Al Jajeh I, Iqbal J, Anshu A, Tan DT. Histological features of Cytomegalovirus-&#173;related corneal graft infections, its associated features and clinical significance. <span class="italic">Br&#160;J Ophthalmol.</span> 2016;100(5):601–606. Epub 2015 Aug&#160;20.</p>
			<p class="reference-mid">Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Corneal endotheliitis associated with evidence of cytomegalovirus infection. <span class="italic">Ophthalmology.</span> 2007;114(4):798–803.</p>
			<p class="reference-last--no-space-">Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. <span class="italic">Ophthalmology.</span> 2008;115(2):292–297.</p>
			</div>
			<p class="h1 ParaOverride-5">DNA Viruses: Adenoviruses</p>
			<div id="Chapt9_Top7">
			<p class="body-text--no-indent-">The Adenoviridae are nonenveloped double-&#173;stranded DNA viruses. Originally isolated in 1953 from surgically removed human adenoids, adenoviruses cause a broad spectrum of diseases, including infections of the upper respiratory tract and ocular surface, meningoencephalitis, acute hemorrhagic cystitis in young boys, diarrhea in children, acute respiratory disease in children and military recruits, and respiratory and hepatic failure in an immunocompromised host. There are 49&#160;serotypes, which are divided into 6&#160;distinct subgroups (labeled&#160;A–F) on the basis of genetic sequencing. Adenovirus subgroups associate broadly with specific clinical syndromes. For instance, subgroup&#160;D adenoviruses are strongly associated with epidemic keratoconjunctivitis (EKC). The nonenveloped protein capsid of all the adenovirus subgroups forms a regular icosahedron. For most adenovirus subgroups, a projecting capsid protein on a cell surface serves as the ligand for the adenovirus receptor, and the interaction of an adjacent cell surface capsid protein with cell surface integrins mediates internalization of the virus.</p>
			<p class="reference-single--no-space- ParaOverride-7">Knipe DM, Howley PM, eds. <span class="italic">Fields’ Virology.</span> 5th&#160;ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2006.</p>
			<p class="h5-text ParaOverride-19"><span class="h5-head">pathogenesis</span> Adenoviruses are transmitted by close contact with ocular or respiratory secretions, contaminated fomites, or contaminated swimming pools. Transmission occurs more readily in populations living in close quarters, such as schools, nursing homes, military housing, and summer camps. Transmission of adenoviruses by contaminated instruments or eyedrops in physicians’ offices may also occur. For this reason, IOP measurements should be taken with an instrument that has a disposable cover.</p>
			<p class="h5-text ParaOverride-19"><span class="h5-head">clinical presentation</span> Each subgroup (A–F) of adenoviruses and, to a lesser degree, each serotype possess unique tissue tropisms that reveal the association of specific adenoviruses with distinct clinical syndromes. Most adenoviral eye disease presents clinically as 1 of 3&#160;classic syndromes:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-17">simple follicular conjunctivitis (multiple serotypes)</li>
				<li class="bullet-list-mid">pharyngoconjunctival fever (most commonly serotype&#160;3 or&#160;7)</li>
				<li class="bullet-list-last ParaOverride-18">EKC (usually serotype 8, 19, or 37, subgroup&#160;D)</li>
			</ul>
			<p class="body-text--no-indent-">The different adenoviral syndromes are indistinguishable early in infection and may be unilateral or bilateral.</p>
			<p class="body-text"><span class="italic">Adenoviral follicular conjunctivitis</span> is self-&#173;limited, not associated with systemic disease, and often so transient that patients do not seek care. Epithelial keratitis, if present, is mild and fleeting. <span class="italic">Pharyngoconjunctival fever</span> is characterized by fever, headache, pharyngitis, follicular conjunctivitis, and preauricular adenopathy. The systemic signs and symptoms may mimic those of influenza. Any associated epithelial keratitis is mild.</p>
			<p class="body-text"><span class="italic">Epidemic keratoconjunctivitis</span> is the only adenoviral syndrome with significant corneal involvement and may be preceded by an upper respiratory tract infection. EKC is bilateral in most patients. One week to 10&#160;days after inoculation, severe follicular conjunctivitis develops, associated with a punctate epithelial keratitis. The conjunctival morphology is follicular but may be obscured by chemosis. Petechial conjunctival hemorrhages and, occasionally, larger subconjunctival hemorrhages can occur. Preauricular adenopathy is prominent. Pseudomembranes or true membranes (<span class="xref-figure">Fig&#160;9-18</span>) occur predominantly on the tarsal conjunctiva and may be missed on cursory examination. Patients report tearing, light sensitivity, and foreign-&#173;body sensation. Large central geographic corneal erosions can develop and may persist for several days despite patching and lubrication. Within 7–14&#160;days after onset of ocular symptoms, multifocal subepithelial (stromal) corneal infiltrates become apparent on slit-lamp examination (<span class="xref-figure">Fig&#160;9-19</span>). Photophobia and reduced vision from adenoviral subepithelial infiltrates may persist for months to years.</p>
			<p class="body-text">Epithelial keratitis occurs because of adenovirus replication within the corneal epithelium. Subepithelial infiltrates are likely caused by an immunopathologic response to viral infection of keratocytes in the superficial corneal stroma. The evolution of keratitis in EKC is summarized in <span class="xref-figure">Figure&#160;9-20</span>. Chronic complications of conjunctival membranes include subepithelial conjunctival scarring, symblepharon formation, and dry eye due to alterations within the lacrimal glands or lacrimal ducts.</p>
			<p class="h5-text ParaOverride-19"><span class="h5-head">laboratory evaluation</span> The diagnosis of EKC is suggested in the setting of bilateral follicular conjunctivitis associated with petechial conjunctival hemorrhages, conjunctival pseudomembrane or frank membrane formation, or, later in the clinical course, the presence of bilateral subepithelial infiltrates. Other adenoviral ocular syndromes have less specific signs, but laboratory diagnosis is only rarely indicated. Although viral cultures readily differentiate adenovirus from HSV infection, the clinical disease typically subsides or resolves before results become available. A rapid immunodetection assay to detect adenovirus antigens in the conjunctiva is available.</p>
			<p class="h5-text"><span class="h5-head">management</span> Therapy for adenoviral ocular infection is primarily supportive. Cool compresses and artificial tears may provide symptomatic relief. Topical combination antibiotic-&#173;corticosteroid drops may be indicated only when the clinical signs, such as mucopurulent discharge, suggest an associated bacterial infection or when a viral cause is less certain.</p>
			<p class="body-text">Topical corticosteroids also reduce photophobia and improve vision impaired by adenoviral subepithelial infiltrates. Because corticosteroids may prolong viral shedding from adenovirus-&#173;infected patients and can lead to worsening of HSV infections, their use should be reserved for patients with clinical signs of adenovirus infection who present with specific indications for treatment, including conjunctival membranes and reduced vision due to bilateral subepithelial infiltrates. Topical corticosteroids will produce rapid resolution of the infiltrates, but it may be difficult to wean patients from them, prolonging the course of the disease. Nonsteroidal anti-&#173;inflammatory drugs are ineffective therapy for adenoviral subepithelial infiltrates, but they may be helpful in preventing recurrence following tapering of the corticosteroids. Topical cyclosporine 1% or other immunomodulatory agents may be considered when other therapies fail.</p>
			<p class="body-text">Actively infected persons readily transmit adenoviruses. Viral shedding may persist for 10–14&#160;days after the onset of clinical signs and symptoms. Transmission can be prevented by personal hygiene measures, including frequent hand washing; cleaning of towels, pillowcases, and handkerchiefs; and disposal of contaminated facial tissues. Individuals who work with the public, in schools, or in health care facilities in particular should consider a temporary leave of absence from work to prevent infecting others, especially those who are already ill. Patients should be considered infectious if they are still hyperemic and tearing. It is more difficult to assess transmissibility in patients treated with topical corticosteroids, who may still shed the virus even though the disease appears to be in a quiet period.</p>
			</div>
			<p class="h1 ParaOverride-20">DNA Viruses: Poxviruses</p>
			<div id="Chapt9_Top8">
			<p class="body-text--no-indent-">The Poxviridae are a large family of enveloped, double-&#173;stranded DNA viruses, with a distinctive brick or ovoid shape and a complex capsid structure. The best-known poxviruses are molluscum contagiosum, vaccinia, and smallpox (variola) virus.</p>
			<p class="h2 ParaOverride-3">Molluscum Contagiosum</p>
			<p class="h5-text ParaOverride-1"><span class="h5-head">pathogenesis</span> Molluscum contagiosum virus is spread by direct contact with infected individuals. Infection produces 1 or more umbilicated nodules on the skin and eyelid margin and, less commonly, on the conjunctiva. Eyelid nodules release viral particles into the tear film.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> A molluscum nodule is smooth, with an umbilicated central core. It is smaller and associated with less inflammation than a keratoacanthoma. Punctate epithelial erosions and, in rare cases, a corneal pannus may occur. Any chronic follicular conjunctivitis should instigate a careful search for eyelid margin molluscum lesions (<span class="xref-figure">Fig&#160;9-21</span>).</p>
			<p class="h5-text"><span class="h5-head">laboratory evaluation and management</span> The molluscum contagiosum virus cannot be cultured using standard techniques. Histologic examination of an expressed or excised nodule shows eosinophilic, intracytoplasmic inclusions (Henderson-&#173;Patterson bodies) within epidermal cells. The diagnosis is based on detection of the characteristic eyelid lesions in the presence of a follicular conjunctivitis. Extensive facial and eyelid molluscum lesions may occur in association with AIDS (<span class="xref-figure">Fig&#160;9-22</span>). Spontaneous resolution occurs but can take months to years. Treatment options include complete excision, cryotherapy, or incision of the central portion of the lesion.</p>
			<p class="h2 ParaOverride-3">Vaccinia</p>
			<p class="body-text--no-indent-">Discussion of vaccinia, the cause of smallpox, was previously removed from the BCSC series because of the worldwide eradication of smallpox. More recently, however, concern that smallpox virus might be used as a biological weapon has prompted the reinstitution of a smallpox vaccination program, especially for military personnel. Ocular complications from self-&#173;inoculation have been reported, including potentially severe periorbital pustules, conjunctivitis, and keratitis. Treatment includes topical trifluridine. Use of vaccinia-&#173;immune globulin (VIG) is controversial but is indicated for severe ocular disease. Concern about the use of VIG stems from limited rabbit studies that have demonstrated a possible increase in corneal scarring. Individuals who are immunosuppressed, atopic, pregnant, breastfeeding, allergic to the vaccine, or living with a high-risk household contact should not receive the vaccine because of the risk of the possibly fatal, progressive vaccinia.</p>
			<p class="reference-first">Fillmore GL, Ward TP, Bower KS, et al. Ocular complications in the Department of Defense Smallpox Vaccination Program. <span class="italic">Ophthalmology.</span> 2004;111(11):2086–2093.</p>
			<p class="reference-last--no-space-">Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia—transmission of vaccinia from smallpox vaccination. <span class="italic">JAMA.</span> 2002;288(15):1901–1905.</p>
			</div>
			<p class="h1">DNA Viruses: Papovaviruses</p>
			<div id="Chapt9_Top9">
			<p class="body-text--no-indent-">Human papovaviruses, also called papillomaviruses (HPV), are small, nonenveloped, double-&#173;stranded DNA viruses with an icosahedral capsid. Persistent viral infection of susceptible epithelial cells induces cellular proliferation and can lead to malignant transformation. Papillomavirus proteins can induce transformation of the cell and loss of senescence. HPV subtypes&#160;6 and 11 are maintained in a latent state within basal epithelial cells as circular episomes with very limited viral gene transcription and low copy number. Early viral gene products stimulate cell growth and lead to a skin wart or a conjunctival papilloma. As HPV-&#173;containing basal epithelial cells mature and differentiate into superficial epithelial cells, they become permissive for complete viral gene expression and produce infectious virus. Neoplastic transformation due to HPV&#160;6 or 11 is very rare. In contrast, HPV&#160;16 and 18 stereotypically integrate their viral genome into host chromosomal DNA, and this in turn is associated with malignant transformation and squamous cell carcinoma. Recently implemented immunization strategies specifically targeted against HPV oncogenes may result in a decreased incidence of these tumors in the future.</p>
			<p class="body-text"><span class="italic">Verrucae</span> and <span class="italic">papillomas</span> are caused by papillomavirus infection of the skin and conjunctival epithelium (<span class="xref-figure">Fig&#160;9-23</span>). Papillomavirus-&#173;associated conjunctival intraepithelial neoplasia and squamous cell carcinoma share many histologic features with similar lesions in the uterine cervix. Treatment of conjunctival papillomas can be frustrating. Medical therapeutic options include systemic cimetidine 30&#160;mg/kg/day in 3&#160;divided doses for 3&#160;months or more, or topical interferon alfa-2b three times a day for the same treatment period. “No-touch” surgical excision with adjuvant cryotherapy is the preferred surgical option and is followed by administration of oral cimetidine or topical interferon, as described above. Seeding of adjacent conjunctiva may occur following surgical excision, resulting in spread. Another neoplasm, Kaposi sarcoma of the skin or conjunctiva, is associated with infection with human herpesvirus&#160;8, not HPV. These entities are discussed in greater detail in Chapter&#160;12.</p>
			<p class="reference-single--no-space- ParaOverride-15">Kaliki S, Arepalli S, Shields CL, et al. Conjunctival papilloma: features and outcomes based on age at initial examination. <span class="italic">JAMA Ophthalmol.</span> 2013;131(5):585–593.</p>
			</div>
			<p class="h1">RNA Viruses</p>
			<div id="Chapt9_Top10">
			<p class="body-text--no-indent-">Patients with eye infections due to RNA viruses present to the ophthalmologist less often than those with infection due to DNA viruses, and these infections most commonly manifest as follicular conjunctivitis associated with an upper respiratory tract infection (<span class="xref-table">Table&#160;9-8</span>). However, certain RNA virus infections may cause pathologic changes in virtually any ocular tissue. For example, influenza virus can induce inflammation in the lacrimal gland, cornea, iris, retina, optic nerve, and other cranial nerves.</p>
			<p class="body-text">The Paramyxoviridae are a family of single-&#173;stranded, enveloped RNA viruses that cause numerous human diseases. The most-&#173;recognized paramyxoviruses are measles and mumps. The classic triad of postnatally acquired measles (rubeola) consists of cough, coryza, and follicular conjunctivitis. Mild epithelial keratitis may be present. Optic neuritis, retinal vascular occlusion, and pigmentary retinopathy occur less commonly. Measles keratopathy, a major source of blindness in the developing world, typically presents as corneal ulceration in malnourished, vitamin&#160;A–deficient children. (For further information on the ocular effects of vitamin&#160;A deficiency, see Chapter&#160;8.) A rare and fatal complication of infection with the measles virus, subacute sclerosing panencephalitis (SSPE), occurs in approximately 1 per 100,000&#160;cases, often years after clinically apparent measles.</p>
			<p class="body-text">Infection with the mumps virus may result in dacryoadenitis, sometimes concurrent with parotid gland involvement. Follicular conjunctivitis, epithelial and stromal keratitis, iritis, trabeculitis, and scleritis have all been reported within the first 2&#160;weeks after onset of parotitis.</p>
			<p class="body-text">Rubella virus (a togavirus), when acquired in utero, may cause microphthalmos, corneal haze, cataracts, iris hypoplasia, iridocyclitis, glaucoma, and salt-and-&#173;pepper pigmentary retinopathy. Congenital ocular abnormalities due to rubella are much worse when maternal infection ensues early in pregnancy. Measles, mumps, and rubella are all uncommon in places where childhood vaccination is regularly performed.</p>
			<p class="body-text">Rabies virus (Rhabdoviridae) is an enveloped virus and can be transmitted via corneal transplant. Corneal biopsy and impression cytology have been useful in the early diagnosis of rabies virus infection.</p>
			<p class="body-text">Acute hemorrhagic conjunctivitis (AHC), caused by enterovirus&#160;70 and coxsackievirus&#160;A24 variant, and, less commonly, adenovirus&#160;11, is one of the most dramatic ocular viral syndromes. Sudden onset of follicular conjunctivitis associated with multiple petechial hemorrhages of bulbar and tarsal conjunctiva characterizes AHC. The hemorrhages may become confluent and resemble those associated with trauma. Eyelid edema, preauricular adenopathy, chemosis, and punctate epithelial keratitis may be associated with infection. AHC is highly contagious and occurs in large and rapidly spreading epidemics. In approximately 1 out of 10,000&#160;cases due to enterovirus&#160;70, a polio-&#173;like paralysis follows; neurologic deficits are permanent in up to one-third of affected individuals.</p>
			<p class="body-text">Retroviruses are positive-&#173;sense, single-&#173;stranded, enveloped RNA viruses that encode a viral enzyme, reverse transcriptase, that assists in conversion of the single-&#173;stranded RNA genome into a circular double-&#173;stranded DNA molecule.</p>
			<p class="body-text">The retrovirus of greatest medical importance is human immunodeficiency virus (HIV), the etiologic agent of AIDS. HIV enters the human host via sexual contact at mucosal surfaces, through breastfeeding, or via blood-&#173;contaminated needles. Sexually transmitted infection is facilitated by uptake of HIV by dendritic cells at mucosal surfaces. CD4<span class="CharOverride-2">+</span> T&#160;lymphocytes are a primary target of the virus, as are dendritic cells and monocyte-&#173;macrophages. Infection of these cell types induces predictable defects of innate and acquired (both humoral and cellular) immunity. Primary viremia results in an infectious mononucleosis-&#173;like HIV prodrome, followed by seeding of the peripheral lymphoid organs and development of a measurable immune response. Conjunctivitis may occur during this seroconversion prodrome in a small number of patients and is self-&#173;limited. Infected patients may remain otherwise asymptomatic for several years, but CD4<span class="CharOverride-2">+</span> T&#160;lymphocytes are progressively depleted. Clinical immunodeficiency eventually develops.</p>
			<p class="body-text">AIDS-&#173;related ocular disorders include HZO, molluscum contagiosum, keratoconjunctivitis sicca, microsporidial keratoconjunctivitis, HIV neuropathy, cryptococcal optic neuritis, retinal microvasculopathy, choroiditis and retinitis due to syphilis, mycobacteria, pneumocystosis, toxoplasmosis, CMV, HSV, and VZV. For more information regarding HIV, see BCSC Section&#160;1, <span class="italic">Update on General Medicine,</span> and Section&#160;9, <span class="italic">Intraocular Inflammation and Uveitis.</span></p>
			<p class="reference-first">Cunningham ET Jr, Margolis TP. Ocular manifestations of HIV infection. <span class="italic">N&#160;Engl J&#160;Med.</span> 1998;<br />339(4):236–244.</p>
			<p class="reference-mid">Lai TY, Wong RL, Luk FO, Chow VW, Chan CK, Lam DS. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-&#173;highly active anti-&#173;retroviral therapy era. <span class="italic">Clin Experiment Ophthalmol.</span> 2011;39(2):99–104.</p>
			<p class="reference-last">Zaidman GW, Billingsley A. Corneal impression test for the diagnosis of acute rabies encephalitis. <span class="italic">Ophthalmology.</span> 1998;105(2):249–251.</p>
		</div>
		</div>
		<div id="_idContainer001" class="Basic-Text-Frame">
			<table id="table001" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-4" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 9-1</span> Relative Prevalence of the Normal Flora of the External Eye</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Microorganisms</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head ParaOverride-21">Normal Conjunctiva</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head ParaOverride-21">Normal Eyelid Margin</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus epidermidis</span></p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body ParaOverride-21">+ + +</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body ParaOverride-21">+ + +</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus aureus</span></p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Micrococcus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Corynebacterium</span> spp (diphtheroids)</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Propionibacterium acnes</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Streptococcus</span> spp<span class="CharOverride-4">*</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21"><span class="math CharOverride-5">±</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Haemophilus influenzae</span><span class="CharOverride-4">*</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21"><span class="CharOverride-6">±</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">–</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Moraxella</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21"><span class="CharOverride-6">±</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">–</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Enteric gram-negative bacilli</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21"><span class="CharOverride-6">±</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">–</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Bacillus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21"><span class="CharOverride-6">±</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">–</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Anaerobic bacteria</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21"><span class="math CharOverride-5">±</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Yeasts (<span class="CharOverride-3">Malassezia furfur</span>, <span class="CharOverride-3">Candida</span> spp, etc)</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">–</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">+</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Filamentous fungi</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21"><span class="math CharOverride-5">±</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body ParaOverride-21">–</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-6">
							<p class="table-body"><span class="CharOverride-3">Demodex</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6">
							<p class="table-body ParaOverride-21">–</p>
						</td>
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6">
							<p class="table-body ParaOverride-21">+ +</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-9">
						<td class="No-Table-Style CellOverride-7" colspan="5">
							<p class="table-footnote"><span class="table-superscript-note-ast-">*</span>More common in children.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer002" class="Basic-Text-Frame">
			<table id="table002" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-10" />
					<col class="_idGenTableRowColumn-11" />
					<col class="_idGenTableRowColumn-12" />
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-11" />
					<col class="_idGenTableRowColumn-16" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="9">
							<p class="table-title"><span class="table-number">Table 9-2</span> Principal Causes of External Ocular Infections</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Condition</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Viruses</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Bacteria</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Fungi</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Parasites</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-17">
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Dermatoblepharitis</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Herpes simplex</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus aureus</span></p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body"><span class="CharOverride-3">—</span></p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Varicella-zoster</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body"><span class="CharOverride-3">Streptococcus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Blepharitis</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Herpes simplex</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">—</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Phthirus pubis</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Molluscum contagiosum</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Moraxella</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Demodex</span> spp</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Conjunctivitis</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Adenovirus</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Chlamydia trachomatis</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">—</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Herpes simplex</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus aureus</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Picornavirus</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Streptococcus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Neisseria gonorrhoeae</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Haemophilus influenzae</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Moraxella</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Keratitis</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Herpes simplex</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Pseudomonas aeruginosa</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Fusarium</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Acanthamoeba </span>spp</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus aureus</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Aspergillus </span>spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus epidermidis</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Candida<br />albicans</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Streptococcus pneumoniae</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Moraxella</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Dacryoadenitis</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Epstein-Barr<br />virus</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus aureus</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">—</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Mumps</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Streptococcus pneumoniae</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-19">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Canaliculitis</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Herpes simplex</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-8">
							<p class="table-body">Actinomycetes</p>
							<p class="table-body"><span class="CharOverride-3">Streptococcus</span> spp</p>
							<p class="table-body"><span class="CharOverride-3">Staphylococcus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body"><span class="CharOverride-3">Candida</span> sp, <span class="CharOverride-3">Aspergillus</span> sp</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-9">
							<p class="table-body">Dacryocystitis</p>
						</td>
						<td class="No-Table-Style CellOverride-9" />
						<td class="No-Table-Style CellOverride-9" />
						<td class="No-Table-Style CellOverride-9" />
						<td class="No-Table-Style CellOverride-10">
							<p class="table-body"><span class="CharOverride-3">Staphylococcus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-9" />
						<td class="No-Table-Style CellOverride-9">
							<p class="table-body"><span class="CharOverride-3">Candida</span> (rare)</p>
						</td>
						<td class="No-Table-Style CellOverride-9" />
						<td class="No-Table-Style CellOverride-9">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-11">
							<p class="table-body"><span class="CharOverride-3">Streptococcus</span> spp</p>
						</td>
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6" />
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer003" class="Basic-Text-Frame">
			<table id="table003" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-20" />
					<col class="_idGenTableRowColumn-21" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-23" />
					<col class="_idGenTableRowColumn-24" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-25">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 9-3</span> Materials for Collecting Eyelid, Conjunctival, and Corneal Specimens <br />for Ocular Microbiology</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Viral Infections</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Chlamydial Infections</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Microbial Infections</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-26">
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Topical anesthetic (proparacaine hydrochloride 0.5%)</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Topical anesthetic <br />(proparacaine <br />hydrochloride 0.5%)</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Topical anesthetic <br />(proparacaine <br />hydrochloride 0.5%)</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Dacron swabs</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Dacron swabs</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Calcium alginate or Dacron swabs</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Spatula</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Spatula</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Spatula</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Glass slides</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Glass slides</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Glass slides</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Acetone fixative</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Methanol or acetone fixative</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Methanol fixative</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Viral transport medium</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Chlamydial transport medium</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Blood agar plate</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Ice</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Ice</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Chocolate agar plate</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12">
							<p class="table-body">Sabouraud dextrose agar plate or brain–heart infusion agar</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body" />
						<td class="No-Table-Style _5-BCSC-table-body">
							<p class="table-body">Nonnutrient agar plate with <span class="CharOverride-3">Enterobacter aerogenes</span> overlay</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-13" />
						<td class="No-Table-Style CellOverride-13" />
						<td class="No-Table-Style CellOverride-13" />
						<td class="No-Table-Style CellOverride-13" />
						<td class="No-Table-Style CellOverride-13">
							<p class="table-body">Thioglycollate or meat broth</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer004" class="Basic-Text-Frame">
			<table id="table004" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-27" />
					<col class="_idGenTableRowColumn-28" />
					<col class="_idGenTableRowColumn-27" />
					<col class="_idGenTableRowColumn-29" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 9-4</span> Commonly Used Stains and Culture Media for Microbial Keratitis</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Suspected Organism</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Stain</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Media</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Aerobic bacteria</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Gram</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Blood agar</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Acridine orange</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Chocolate agar</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Thioglycollate broth</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Anaerobic bacteria</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Gram</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Anaerobic blood agar</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Acridine orange</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Phenylethyl alcohol agar in anaerobic chamber</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Thioglycollate or chopped meat broth</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Mycobacteria</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Gram</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Blood agar</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Acid-fast</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Lowenstein-Jensen agar</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Lectin</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Fungi</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Gram</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Blood agar (25ºC)</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Acridine orange</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Sabouraud agar (25ºC)</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Calcofluor white</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Brain–heart infusion agar (25ºC)</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-19">
						<td class="No-Table-Style CellOverride-15 _idGenCellOverride-2" rowspan="3" colspan="2">
							<p class="table-body"><span class="CharOverride-3">Acanthamoeba</span></p>
						</td>
						<td class="No-Table-Style CellOverride-16 _idGenCellOverride-2" rowspan="3">
							<p class="table-body">Acridine orange</p>
							<p class="table-body">Calcofluor white</p>
							<p class="table-body">Gram</p>
							<p class="table-body">Giemsa</p>
							<p class="table-body">Indirect immunofluorescence antibody</p>
						</td>
						<td class="No-Table-Style CellOverride-17 _idGenCellOverride-2" rowspan="3" />
						<td class="No-Table-Style CellOverride-18">
							<p class="table-body">Nonnutrient agar with bacterial overlay <span class="CharOverride-3">(Enterobacter aerogenes, Escherichia coli)</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-19">
							<p class="table-body">Blood agar</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-30">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-20">
							<p class="table-body">Buffered charcoal–yeast extract agar</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer007">
				<div id="_idContainer005" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2861.png" alt="" />
				</div>
				<div id="_idContainer006" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-21"><span class="figure-number">Figure 9-1</span> “C” streaks on a chocolate blood agar plate. <span class="figure-source-note">(Courtesy of James Chodosh, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer010">
				<div id="_idContainer008" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2888.jpg" alt="" />
				</div>
				<div id="_idContainer009" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-2</span> Skin vesicles of herpes simplex virus (HSV) dermatoblepharitis. <span class="figure-source-note">(Courtesy of </span><span class="figure-source-note">James Chodosh, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer013">
				<div id="_idContainer011" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2889.png" alt="" />
				</div>
				<div id="_idContainer012" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-4</span> Fluorescein staining of an eye with primary HSV infection demonstrates characteristic upper eyelid margin ulcers and a coarse dendritic epithelial keratitis. <span class="figure-source-note">(Courtesy of James Chodosh, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer016">
				<div id="_idContainer014" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-7774.jpg" alt="" />
				</div>
				<div id="_idContainer015" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-3</span>  Eyelid margin ulcers characteristic of primary ocular HSV infection after vesicular rupture. <span class="figure-source-note">(Courtesy of Cornea Service, Paulista School of Medicine, Federal University of São Paulo.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer017" class="Basic-Text-Frame">
			<table id="table005" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-31" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-33" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-34" />
					<col class="_idGenTableRowColumn-35" />
					<col class="_idGenTableRowColumn-36" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">Table 9-5</span> Antiviral Agents in External/Corneal Infections With Herpes Simplex Virus</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-25">
						<td class="No-Table-Style CellOverride-21">
							<p class="table-column-head">Agent</p>
						</td>
						<td class="No-Table-Style CellOverride-21" />
						<td class="No-Table-Style CellOverride-21">
							<p class="table-column-head">Mechanism of Action</p>
						</td>
						<td class="No-Table-Style CellOverride-21" />
						<td class="No-Table-Style CellOverride-21">
							<p class="table-column-head">Administration</p>
						</td>
						<td class="No-Table-Style CellOverride-21" />
						<td class="No-Table-Style CellOverride-21">
							<p class="table-column-head">Dosage for Acute Disease</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-17">
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Vidarabine</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Purine analogue</p>
							<p class="table-body">Inhibits DNA polymerase</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">3% ophthalmic ointment<span class="CharOverride-4">*</span></p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">5<span class="math CharOverride-5">×</span>/day for 10 days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Trifluridine</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Pyrimidine analogue</p>
							<p class="table-body">Blocks DNA synthesis</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">1% ophthalmic solution</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">8<span class="math CharOverride-5">×</span>/day for 10 days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-37">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Acyclovir</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Activated by HSV thymidine kinase to inhibit viral DNA polymerase</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">3% ophthalmic <br />ointment<span class="table-superscript">†</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">5<span class="math CharOverride-5">×</span>/day for 10 days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-19">
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">200, 400, 800 mg; 200&#160;mg/<br />5 mL suspension</p>
							<p class="table-body">5% dermatologic ointment<span class="table-superscript">‡</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">400 mg 5<span class="math CharOverride-5">×</span>/day for 10 days</p>
							<p class="table-body">6<span class="math CharOverride-5">×</span>/day for 7 days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Famciclovir<span class="CharOverride-7">§</span></p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Prodrug of penciclovir</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">125, 250, 500 mg</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">250 mg 3<span class="math CharOverride-5">×</span>/day for 10 days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Valacyclovir<span class="CharOverride-7">§</span></p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">L-valyl ester of acyclovir</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">500, 1000 mg</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">1000 mg 2<span class="math CharOverride-5">×</span>/day for 10 days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-38">
						<td class="No-Table-Style CellOverride-22">
							<p class="table-body">Valganciclovir</p>
						</td>
						<td class="No-Table-Style CellOverride-22" />
						<td class="No-Table-Style CellOverride-22">
							<p class="table-body">L-valyl ester of <br />ganciclovir</p>
						</td>
						<td class="No-Table-Style CellOverride-22" />
						<td class="No-Table-Style CellOverride-22">
							<p class="table-body">450 mg</p>
						</td>
						<td class="No-Table-Style CellOverride-22" />
						<td class="No-Table-Style CellOverride-22">
							<p class="table-body">Induction: 900 mg (two 450-mg tablets) 2<span class="math CharOverride-5">×</span>/day for 21 days</p>
							<p class="table-body">Maintenance: 900&#160;mg (two 450-mg tablets) 1<span class="math CharOverride-5">×</span>/day</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style CellOverride-23">
							<p class="table-body">Penciclovir</p>
						</td>
						<td class="No-Table-Style CellOverride-23" />
						<td class="No-Table-Style CellOverride-23">
							<p class="table-body">Inhibits viral DNA polymerase</p>
						</td>
						<td class="No-Table-Style CellOverride-23" />
						<td class="No-Table-Style CellOverride-23">
							<p class="table-body">1% dermatologic cream<span class="table-superscript">‡</span></p>
						</td>
						<td class="No-Table-Style CellOverride-23" />
						<td class="No-Table-Style CellOverride-23">
							<p class="table-body">8<span class="math CharOverride-5">×</span>/day for 4 days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-39">
						<td class="No-Table-Style CellOverride-24">
							<p class="table-body">Ganciclovir</p>
						</td>
						<td class="No-Table-Style CellOverride-24" />
						<td class="No-Table-Style CellOverride-24">
							<p class="table-body">Cytomegalovirus nucleoside analogue </p>
							<p class="table-body">Inhibits DNA polymerase</p>
						</td>
						<td class="No-Table-Style CellOverride-24" />
						<td class="No-Table-Style CellOverride-24">
							<p class="table-body">0.15% topical ophthalmic gel</p>
						</td>
						<td class="No-Table-Style CellOverride-24" />
						<td class="No-Table-Style CellOverride-24">
							<p class="table-body">5<span class="math CharOverride-5">×</span>/day until <br />epithelium heals; then 3<span class="math CharOverride-5">×</span>/day for 7&#160;days</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-40">
						<td class="No-Table-Style CellOverride-25" colspan="7">
							<p class="table-footnote"><span class="table-superscript-note-ast-">*</span>&#9;No longer manufactured; can be obtained through compounding pharmacies.</p>
							<p class="table-footnote"><span class="table-superscript-notes">†</span><span class="table-superscript-notes">&#9;</span>Not commercially available in the United States.</p>
							<p class="table-footnote"><span class="table-superscript-notes">‡&#9;</span>Not for ophthalmic use.</p>
							<p class="table-footnote"><span class="CharOverride-7">§</span><span class="table-superscript-notes">&#9;</span>Optimal dose for ocular disease not determined.</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-41">
						<td class="No-Table-Style CellOverride-26" colspan="7" />
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer020">
				<div id="_idContainer018" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-9311.png" alt="" />
				</div>
				<div id="_idContainer019" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-5</span> <span class="figure-caption-bold">A,</span>&#160;Punctate epithelial keratitis <span class="figure-caption-italic">(arrows)</span>; the lesion was culture-&#173;positive for HSV. <span class="figure-caption-bold">B,</span>&#160;Note the atypical raised edges and depressed center. <span class="figure-source-note">(Courtesy of Woodford&#160;S. Van Meter, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer023">
				<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2890.png" alt="" />
				</div>
				<div id="_idContainer022" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-6</span> Rose bengal staining of herpetic epithelial keratitis outlines a typical dendrite. <span class="figure-source-note">(Cou</span><span class="figure-source-note">r</span><span class="figure-source-note">tesy of James Chodosh, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer026">
				<div id="_idContainer024" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-7775.png" alt="" />
				</div>
				<div id="_idContainer025" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-7</span> Combined fluorescein and rose bengal staining of geographic HSV keratitis. <span class="figure-source-note">(Cou</span><span class="figure-source-note">r</span><span class="figure-source-note">tesy of Cornea Service, Paulista School of Medicine, Federal University of São Paulo.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer029">
				<div id="_idContainer027" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2864.png" alt="" />
				</div>
				<div id="_idContainer028" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-8</span> Herpetic geographic epithelial keratitis. <span class="figure-source-note">(Reprinted with permission from Chodosh&#160;J. Viral keratitis. In: Parrish RK, ed. </span><span class="figure-source-emphasis">The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology.</span><span class="figure-source-note"> Boston: Current Medicine; 1999.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer032">
				<div id="_idContainer030" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2865.png" alt="" />
				</div>
				<div id="_idContainer031" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-9</span> Residual stromal inflammation following dendritic epithelial keratitis may leave the impression of a ghost image of the dendrite. <span class="figure-source-note">(Reprinted with permission from Chodosh&#160;J. Viral keratitis. In: Parrish RK, ed. </span><span class="figure-source-emphasis">The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology.</span><span class="figure-source-note"> Boston: Current Medicine; 1999.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer035">
				<div id="_idContainer033" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2866.png" alt="" />
				</div>
				<div id="_idContainer034" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-10</span> Herpetic interstitial keratitis (nonnecrotizing). <span class="figure-source-note">(Reprinted with permission from Chodosh&#160;J. Viral keratitis. In: Parrish RK, ed. </span><span class="figure-source-emphasis">The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology.</span><span class="figure-source-note"> Boston: Current Medicine; 1999.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer038">
				<div id="_idContainer036" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2867.png" alt="" />
				</div>
				<div id="_idContainer037" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-11</span> Herpetic disciform keratitis (nonnecrotizing). <span class="figure-source-note">(Reprinted with permission from Chodosh&#160;J. Viral keratitis. In: Parrish RK, ed. </span><span class="figure-source-emphasis">The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology.</span><span class="figure-source-note"> Boston: Current Medicine; 1999.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer041">
				<div id="_idContainer039" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2868.png" alt="" />
				</div>
				<div id="_idContainer040" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-21"><span class="figure-number">Figure 9-12</span> Necrotizing herpetic stromal keratitis.</p>
				</div>
			</div>
		</div>
		<div id="_idContainer042" class="Basic-Text-Frame">
			<table id="table006" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-23" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-42" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-43" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-44" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-45" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-5">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="9">
							<p class="table-title"><span class="table-number">Table 9-6</span> The Herpetic Eye Disease Study</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">No.</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Question</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Study Design</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Findings</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Comment</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-46">
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">1</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Do topical corticosteroids treat stromal keratitis?</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">106 patients with stromal keratitis randomized to topical corticosteroids or placebo for 10&#160;weeks. Treatment started with prednisolone 1% 8<span class="math CharOverride-5">×</span>/day and tapered to prednisolone 1/8<span class="CharOverride-1"> </span>% once a day. Both groups received topical trifluridine.</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Yes. Topical corticosteroids significantly decreased stromal inflammation and shortened duration of keratitis.</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">The optimal corticosteroid regimen was not evaluated. Some patients respond to less corticosteroid and some may need a shorter/longer taper. Delaying corticosteroids for several weeks had no detrimental effect on vision.</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-47">
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">2</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Is oral acyclovir (in addition to treatment with trifluridine and corticosteroids) helpful in treating stromal keratitis?</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">104 patients with stromal keratitis randomized to oral acyclovir (400&#160;mg 5<span class="math CharOverride-5">×</span>/day) vs placebo for a 10-week course. Both groups also received topical prednisolone and trifluridine.</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">No. Treatment of nonnecrotizing stromal keratitis with oral acyclovir was not beneficial.</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Insufficient patients with necrotizing stromal keratitis to comment on effectiveness of acyclovir.</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-19">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">3</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Is treatment-dose oral acyclovir helpful in treating HSV iritis?</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">50 patients with iritis treated with oral acyclovir (400 mg 5<span class="math CharOverride-5">×</span>/day) vs placebo for 10-week course.</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Too few patients. A nonstatistically significant trend favoring the use of oral acyclovir.</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Many clinicians favor use of oral acyclovir for treatment of HSV iridocyclitis.</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-37">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">4</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Does oral acyclovir prevent stromal keratitis and iritis from developing in patients with epithelial keratitis?</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">287 patients with epithelial keratitis received 3-week oral acyclovir <br />(400 mg 5<span class="math CharOverride-5">×</span>/day) vs placebo; followed for 12 months.</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">No. No difference in development of stromal keratitis or iritis.</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Best predictor for stromal keratitis is history of previous stromal keratitis.</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-47">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">5</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Does acyclovir prophylaxis minimize HSV recurrences?</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">703 patients with inactive disease<br />and off medications randomized <br />to oral acyclovir (400 mg 2<span class="math CharOverride-5">×</span>/day) <br />vs placebo for 12 months; followed for 18 months.</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Recurrent ocular disease was less (about 50%) in acyclovir prophylaxis group, especially in patients with recurrent stromal keratitis.</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Long-term prophylaxis recommended for patients with recurrent HSV stromal keratitis.</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-48">
						<td class="No-Table-Style CellOverride-27">
							<p class="table-body">6</p>
						</td>
						<td class="No-Table-Style CellOverride-27" />
						<td class="No-Table-Style CellOverride-27">
							<p class="table-body">What triggers HSV recurrences?</p>
						</td>
						<td class="No-Table-Style CellOverride-27" />
						<td class="No-Table-Style CellOverride-27">
							<p class="table-body">308 patients kept weekly log of <br />stress, systemic infections, sunlight exposure, menstruation, CL wear, and eye injury.</p>
						</td>
						<td class="No-Table-Style CellOverride-27" />
						<td class="No-Table-Style CellOverride-27">
							<p class="table-body">No factors confirmed as triggers for recurrence.*</p>
						</td>
						<td class="No-Table-Style CellOverride-27" />
						<td class="No-Table-Style CellOverride-27" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-40">
						<td class="No-Table-Style _8-BCSC-table-note" colspan="9">
							<p class="table-footnote"><span class="CharOverride-4">*</span>&#9;With 33 valid recurrences, none of these factors was associated with a recurrence of ocular HSV infection. When the 26 recurrences excluded for being reported late were examined, high stress and systemic infection were found to have been reported significantly more frequently than in the 33 valid responses. (Kip KE, Cohen F, Cole SR, et al; Herpetic Eye Disease Study Group. Recall bias in a prospective cohort study of acute time-varying exposures: example from the Herpetic Eye Disease Study. <span class="CharOverride-3">J Clin Epidemiol.</span> 2001;54(5):482–487).</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer043" class="Basic-Text-Frame">
			<table id="table007" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-49" />
					<col class="_idGenTableRowColumn-50" />
					<col class="_idGenTableRowColumn-24" />
					<col class="_idGenTableRowColumn-50" />
					<col class="_idGenTableRowColumn-51" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-25">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 9-7</span> Differentiating Features of Eye Disease Caused by Herpes Simplex Virus and Reactivation of Varicella-Zoster Virus</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Herpes Simplex Virus</p>
						</td>
						<td class="No-Table-Style CellOverride-2" />
						<td class="No-Table-Style CellOverride-2">
							<p class="table-column-head">Varicella-Zoster Virus</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Dermatomal distribution</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Incomplete</p>
						</td>
						<td class="No-Table-Style CellOverride-3" />
						<td class="No-Table-Style CellOverride-3">
							<p class="table-body">Complete</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Pain</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Moderate</p>
						</td>
						<td class="No-Table-Style CellOverride-4" />
						<td class="No-Table-Style CellOverride-4">
							<p class="table-body">Severe</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-47">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Dendrite morphology</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Central epithelial ulceration with terminal bulbs; geographic in presence of corticosteroids</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Smaller without central ulceration or terminal bulbs; dendritiform mucous plaques <br />occur later</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Skin scarring</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">No</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Common</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Postherpetic neuralgia</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">No</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Common</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Iris atrophy</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Patchy</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Sectoral</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Bilateral involvement</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Uncommon</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">No</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Recurrent epithelial keratitis</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Common</p>
						</td>
						<td class="No-Table-Style CellOverride-5" />
						<td class="No-Table-Style CellOverride-5">
							<p class="table-body">Rare</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style CellOverride-6">
							<p class="table-body">Corneal hypoesthesia</p>
						</td>
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6">
							<p class="table-body">Focal or diffuse</p>
						</td>
						<td class="No-Table-Style CellOverride-6" />
						<td class="No-Table-Style CellOverride-6">
							<p class="table-body">May be severe</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer046">
				<div id="_idContainer044" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2869.png" alt="" />
				</div>
				<div id="_idContainer045" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-21"><span class="figure-number">Figure 9-13</span> Herpes zoster ophthalmicus (HZO). <span class="figure-source-note">(Courtesy of Vincent&#160;P. deLuise, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer049">
				<div id="_idContainer047" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2870.png" alt="" />
				</div>
				<div id="_idContainer048" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-21"><span class="figure-number">Figure 9-14</span> Nummular keratitis of HZO. <span class="figure-source-note">(Courtesy of Rhea&#160;L. Siatkowski, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer052">
				<div id="_idContainer050" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2871.png" alt="" />
				</div>
				<div id="_idContainer051" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-15</span> Lipid keratopathy following HZO. <span class="figure-source-note">(Reprinted with permission from Chodosh&#160;J. Viral keratitis. In: Parrish RK, ed. </span><span class="figure-source-emphasis">The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology.</span><span class="figure-source-note"> Boston: Current Medicine; 1999.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer055">
				<div id="_idContainer053" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2872.png" alt="" />
				</div>
				<div id="_idContainer054" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-16</span> Interstitial keratitis caused by Epstein-&#173;Barr virus. <span class="figure-source-note">(Reprinted with permission from Ch</span><span class="figure-source-note">o</span><span class="figure-source-note">dosh&#160;J. Viral keratitis. In: Parrish RK, ed. </span><span class="figure-source-emphasis">The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology.</span><span class="figure-source-note"> Boston: Current Medicine; 1999.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer058">
				<div id="_idContainer056" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-17</span> Clusters of keratic precipitates in cytomegalovirus corneal endotheliitis. <span class="figure-source-note">(Cou</span><span class="figure-source-note">r</span><span class="figure-source-note">-<br />tesy of Cornea Service, Paulista School of Medicine, Federal University of São Paulo.)</span></p>
				</div>
				<div id="_idContainer057" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-7776.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer061">
				<div id="_idContainer059" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-18</span> Conjunctival membranes in a patient with epidemic keratoconjunctivitis (EKC). <span class="figure-source-note">(Courtesy of James Chodosh, MD.)</span></p>
				</div>
				<div id="_idContainer060" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2885.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer064">
				<div id="_idContainer062" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2887.png" alt="" />
				</div>
				<div id="_idContainer063" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-19</span> Subepithelial corneal infiltrates in a patient with EKC. <span class="figure-source-note">(Courtesy of Vincent&#160;P. deLuise, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer067">
				<div id="_idContainer065" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2709.png" alt="" />
				</div>
				<div id="_idContainer066" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-20</span> Schematic drawing illustrating the natural progression of specific corneal epithelial and stromal pathology in EKC. <span class="figure-caption-italic">Stage&#160;0,</span> Poorly staining, minute punctate opacities within the corneal epithelium. <span class="figure-caption-italic">Stage&#160;I,</span> Fine punctate epithelial keratitis (PEK). <span class="figure-caption-italic">Stage&#160;II,</span> Fine and coarse PEK. Stains brightly with rose bengal. <span class="figure-caption-italic">Stage&#160;III,</span> Coarse granular infiltrates within deep epithelium, early subepithelial infiltrates, diminished PEK. <span class="figure-caption-italic">Stage&#160;IV,</span> Classic subepithelial infiltrates without PEK. <span class="figure-caption-italic">Stage&#160;V,</span> Punctate epithelial granularity adjacent to and distinct from the subepithelial infiltrates. <span class="figure-source-note">(Adapted from Jones DB, Matoba AY, Wilhelmus KR. </span><span class="figure-source-emphasis">Problem solving in corneal and exte</span><span class="figure-source-emphasis">r</span><span class="figure-source-emphasis">nal diseases.</span><span class="figure-source-note"> Course 626, presented at the American Academy of Ophthalmology. Atlanta, GA; 1995.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer070">
				<div id="_idContainer068" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-7779.png" alt="" />
				</div>
				<div id="_idContainer069" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-21</span> Multiple molluscum contagiosum nodules, associated with a follicular conjunctivitis in an immunocompetent child. <span class="figure-source-note">(Reprinted with permission from Tu&#160;EY. Conjunctivitis. In: Schlossberg&#160;D, ed.</span> <span class="figure-source-emphasis">Clinical Infectious Disease. </span><span class="figure-source-note">3rd&#160;ed</span>. <span class="figure-source-note">New York: Cambridge University Press; 2008.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer073">
				<div id="_idContainer071" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 9-22</span> Multiple molluscum contagiosum lesions on the eyelid of a patient with AIDS. <span class="figure-source-note">(Courtesy of James Chodosh, MD.)</span></p>
				</div>
				<div id="_idContainer072" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-2874.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer076">
				<div id="_idContainer074" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch09_p205-242-web-resources/image/AAX-7780.png" alt="" />
				</div>
				<div id="_idContainer075" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-21"><span class="figure-number">Figure 9-23</span> Conjunctival papillomas. <span class="figure-source-note">(Courtesy of Elmer&#160;Y. Tu, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer077" class="Basic-Text-Frame">
			<table id="table008" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-52" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-49" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-53" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 9-8</span> RNA Viruses Known to Cause Ocular Surface Disease</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-28">
							<p class="table-column-head">Virus Family</p>
						</td>
						<td class="Basic-Table CellOverride-28" />
						<td class="Basic-Table CellOverride-28">
							<p class="table-column-head">Virus</p>
						</td>
						<td class="Basic-Table CellOverride-28" />
						<td class="Basic-Table CellOverride-28">
							<p class="table-column-head">Clinical Syndrome</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-29">
							<p class="table-body">Retroviridae</p>
						</td>
						<td class="Basic-Table CellOverride-29" />
						<td class="Basic-Table CellOverride-29">
							<p class="table-body">Human immunodeficiency virus</p>
						</td>
						<td class="Basic-Table CellOverride-29" />
						<td class="Basic-Table CellOverride-29">
							<p class="table-body">Seroconversion conjunctivitis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-37">
						<td class="Basic-Table CellOverride-30">
							<p class="table-body">Orthomyxovirus</p>
						</td>
						<td class="Basic-Table CellOverride-30" />
						<td class="Basic-Table CellOverride-30">
							<p class="table-body">Influenza</p>
						</td>
						<td class="Basic-Table CellOverride-30" />
						<td class="Basic-Table CellOverride-30">
							<p class="table-body">Follicular conjunctivitis</p>
							<p class="table-body">Inflammation of the lacrimal gland, cornea, iris, retina, optic nerve, and other cranial nerves</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Paramyxoviridae</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Avulavirus</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Newcastle disease</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Measles (rubeola)</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Follicular conjunctivitis, measles keratopathy</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Mumps</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Follicular conjunctivitis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-37">
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Togavirus </p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Rubella</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Congenital rubella syndrome: salt-and-pepper retinopathy, microphthalmos, cataract, deafness, congenital heart disease, other systemic abnormalities</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Rhabdoviridae</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Rabies</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Transmission via corneal transplant</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Picornaviridae</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Rhinovirus</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Common cold</p>
							<p class="table-body">Follicular conjunctivitis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Enterovirus 70</p>
						</td>
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31">
							<p class="table-body">Acute hemorrhagic conjunctivitis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32">
							<p class="table-body">Coxsackievirus A24</p>
						</td>
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32">
							<p class="table-body">Acute hemorrhagic conjunctivitis</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
	</body>
</html>
